Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI.
The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications.
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.
A reagent that is used to neutralize peptide terminal amino groups.
A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.
An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.
Inflammation of any segment of the ILEUM and the ILEOCECAL VALVE.
A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
A NOD signaling adaptor protein that contains two C-terminal leucine-rich domains which recognize bacterial PEPTIDOGLYCAN. It signals via an N-terminal capase recruitment domain that interacts with other CARD SIGNALING ADAPTOR PROTEINS such as RIP SERINE-THEONINE KINASES. The protein plays a role in the host defense response by signaling the activation of CASPASES and the MAP KINASE SIGNALING SYSTEM. Mutations of the gene encoding the nucleotide oligomerization domain 2 protein have been associated with increased susceptibility to CROHN DISEASE.
Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.
Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)
Substances that reduce or suppress INFLAMMATION.
A member of the S-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis. It is a complex of a light chain (CALGRANULIN A) and a heavy chain (CALGRANULIN B). L1 binds calcium through an EF-hand motif, and has been shown to possess antimicrobial activity.
The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas).
The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
Endoscopic examination, therapy or surgery of the luminal surface of the colon.
A species of HELICOBACTER that colonizes the CECUM and COLON of several strains of MICE, and is associated with HEPATITIS and carcinogenesis.
INFLAMMATION of the MUCOUS MEMBRANE of the RECTUM, the distal end of the large intestine (INTESTINE, LARGE).
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
A collective genome representative of the many organisms, primarily microorganisms, existing in a community.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
A segment of the LOWER GASTROINTESTINAL TRACT that includes the CECUM; the COLON; and the RECTUM.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.
Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
Changes in quantitative and qualitative composition of MICROBIOTA. The changes may lead to altered host microbial interaction or homeostatic imbalance that can contribute to a disease state often with inflammation.
Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
Antibacterial, potentially toxic, used to treat certain skin diseases.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.
A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7.
Acute INFLAMMATION in the INTESTINAL MUCOSA of the continent ileal reservoir (or pouch) in patients who have undergone ILEOSTOMY and restorative proctocolectomy (PROCTOCOLECTOMY, RESTORATIVE).
Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation.
A member of tumor necrosis factor superfamily found on ENDOTHELIAL CELLS that plays a role in the inhibition of endothelial cell growth and PHYSIOLOGIC ANGIOGENESIS.
Excision of a portion of the colon or of the whole colon. (Dorland, 28th ed)
A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
The theory that infectious agents, symbiotic microorganisms, and parasites are normal stimulants for the maturation of the immune system toward a balanced immune response. The theory predicts that lack of such stimulation leads to allergies and AUTOIMMUNE DISEASES.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Inflammation of the RECTUM and the distal portion of the COLON.
Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.
Differentiated epithelial cells of the INTESTINAL MUCOSA, found in the basal part of the intestinal crypts of Lieberkuhn. Paneth cells secrete GROWTH FACTORS, digestive enzymes such as LYSOZYME and antimicrobial peptides such as cryptdins (ALPHA-DEFENSINS) into the crypt lumen.
A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR (pouch). In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.
Endoscopic examination, therapy or surgery of the gastrointestinal tract.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
A metallic element, atomic number 49, atomic weight 114.82, symbol In. It is named from its blue line in the spectrum. (From Dorland, 28th ed)
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show larger-than-normal band of subepithelial COLLAGEN.
A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
Adrenal cortex hormones are steroid hormones produced by the outer portion of the adrenal gland, consisting of glucocorticoids, mineralocorticoids, and androgens, which play crucial roles in various physiological processes such as metabolism regulation, stress response, electrolyte balance, and sexual development and function.
A genus of gram-negative, spiral-shaped bacteria that has been isolated from the intestinal tract of mammals, including humans. It has been associated with PEPTIC ULCER.
Non-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel.
An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
Inflammation of any segment of the SMALL INTESTINE.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Surgical creation of an external opening into the ILEUM for fecal diversion or drainage. This replacement for the RECTUM is usually created in patients with severe INFLAMMATORY BOWEL DISEASES. Loop (continent) or tube (incontinent) procedures are most often employed.
Antibodies produced by a single clone of cells.
The full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche such as an organism, soil, a body of water, etc.
Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.
An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Tumors or cancer of the COLON.
A segment of the COLON between the RECTUM and the descending colon.
Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.
The blind sac or outpouching area of the LARGE INTESTINE that is below the entrance of the SMALL INTESTINE. It has a worm-like extension, the vermiform APPENDIX.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
A pathological condition characterized by the presence of a number of COLONIC DIVERTICULA in the COLON. Its pathogenesis is multifactorial, including colon aging, motor dysfunction, increases in intraluminal pressure, and lack of dietary fibers.
A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.
The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC).
The treatment of immune system diseases by deliberate infestation with helminths. This therapy is partly based on the HYGIENE HYPOTHESIS which states that the absence of parasites increases immune dysregulation because of the lack of stimulation of REGULATORY T-CELLS.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions.
A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.
A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1.
A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-23 is comprised of a unique 19 kDa subunit and 40 kDa subunit that is shared with INTERLEUKIN-12. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells
An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN (enterocutaneous fistula). Internal intestinal fistula can be connected to a number of organs, such as STOMACH (gastrocolic fistula), the BILIARY TRACT (cholecystoduodenal fistula), or the URINARY BLADDER of the URINARY TRACT (colovesical fistula). Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures (MEDICAL ERRORS).
The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.
The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.
Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
A pouch or sac opening from the COLON.
A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show infiltration of LYMPHOCYTES in the superficial EPITHELIUM and the underlying connective tissue (lamina propria).
Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).
Measurement of rate of settling of erythrocytes in anticoagulated blood.
The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
Sacs or reservoirs created to function in place of the COLON and/or RECTUM in patients who have undergone restorative proctocolectomy (PROCTOCOLECTOMY, RESTORATIVE).
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.
The giving of drugs, chemicals, or other substances by mouth.
Surgery performed on the digestive system or its parts.
Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Elements of limited time intervals, contributing to particular results or situations.
The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.
Tumors or cancer of the INTESTINES.
CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.
Creation of an artificial external opening or fistula in the intestines.
A NOD-signaling adaptor protein that contains a C-terminal leucine-rich domain which recognizes bacterial PEPTIDOGLYCAN. It signals via an N-terminal caspase recruitment domain that interacts with other CARD SIGNALING ADAPTOR PROTEINS such as RIP SERINE-THEONINE KINASES. It plays a role in the host defense response by signaling the activation of CASPASES and the MAP KINASE SIGNALING SYSTEM.
A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach.
Subset of helper-effector T-lymphocytes which synthesize and secrete IL-17, IL-17F, and IL-22. These cytokines are involved in host defenses and tissue inflammation in autoimmune diseases.
Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Inflammation of the COLONIC DIVERTICULA, generally with abscess formation and subsequent perforation.
The segment of LARGE INTESTINE between TRANSVERSE COLON and the SIGMOID COLON.
Endoscopic examination, therapy or surgery of the sigmoid flexure.
Any purulent skin disease (Dorland, 27th ed).
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*27 allele family.
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. (1/2435)

Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, typically starting in early adulthood. IBD is subdivided into two subtypes, on the basis of clinical and histologic features: Crohn disease and ulcerative colitis (UC). Previous genomewide searches identified regions harboring susceptibility loci on chromosomes 1, 3, 4, 7, 12, and 16. To expand our understanding of the genetic risk profile, we performed a 9-cM genomewide search for susceptibility loci in 268 families containing 353 affected sibling pairs. Previous linkages on chromosomes 12 and 16 were replicated, and the chromosome 4 linkage was extended in this sample. New suggestive evidence for autosomal linkages was observed on chromosomes 1, 6, 10, and 22, with LOD scores of 2.08, 2.07, 2.30, and 1.52, respectively. A maximum LOD score of 1.76 was observed on the X chromosome, for UC, which is consistent with the clinical association of IBD with Ullrich-Turner syndrome. The linkage finding on chromosome 6p is of interest, given the possible contribution of human leukocyte antigen and tumor necrosis-factor genes in IBD. This genomewide linkage scan, done with a large family cohort, has confirmed three previous IBD linkages and has provided evidence for five additional regions that may harbor IBD predisposition genes.  (+info)

Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review. (2/2435)

We reviewed the literature and the manufacturer's U.S. clinical data pool for safety data on long-term administration of ciprofloxacin (Bayer, West Haven, CT). Only controlled clinical trials including patients treated for >30 days were selected. We identified 636 patients by literature search and 413 patients in the Bayer U.S. database who fulfilled our search criteria; the average treatment duration for these patients was 130 and 80 days, respectively. Main indications for long-term therapy were osteomyelitis, skin and soft-tissue infection, prophylaxis for urinary tract infection, mycobacterial infections, and inflammatory bowel disease. Adverse events, premature discontinuation of therapy, and deaths occurred at a similar frequency in both treatment arms. Most adverse events occurred early during therapy with little increase in frequency over time. As with short-term therapy, gastrointestinal events were more frequent than central nervous system or skin reactions, but pseudomembranous colitis was not observed. No previously unknown adverse events were noted. We conclude that ciprofloxacin is tolerated as well as other antibiotics when extended courses of therapy are required.  (+info)

Evidence of T cell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease states. (3/2435)

T cell activation, as defined by expression of relevant cell surface molecules, such as the interleukin-2 receptor (CD25), is increased in many chronic relapsing diseases, including inflammatory bowel disease (IBD). These T cells are generally activated through contact of their clonotypic T cell receptor (TCR) with a peptide antigen presented by a major histocompatibility complex molecule. One of the putative antigenic contact sites for the TCR is the third complementarity determining region (CDR3) of the TCR beta-chain variable region (TCRBV). Therefore, analysis of the TCRBV CDR3 provides insight into the diversity of antigens encountered by a given T cell population. This study evaluated the TCRBV CDR3 usage of the activated intestinal lymphocytes from human subjects with IBD, diverticulitis (inflammatory control), and a normal tissue control. Public patterns, as demonstrated by shared TCRBV CDR3 amino acid sequences of activated intestinal T cell subpopulations, were observed. In particular, a public pattern of TCRBV22, a conserved valine in the fifth position, and use of TCRBJ2S1 or TCRBJ2S5 was present in three of four Crohn's disease subjects while not present in the ulcerative colitis subjects. However, the private patterns of TCRBV CDR3 region amino acid sequences were far more striking and easily demonstrated in all individuals studied, including a normal noninflammatory control. Thus we conclude that selective antigenic pressures are prevalent among an individual's activated intestinal lymphocytes.  (+info)

Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. (4/2435)

We studied the induction, severity and rate of progression of inflammatory bowel disease (IBD) induced in SCID mice by the adoptive transfer of low numbers of the following purified BALB/c CD4+ T cell subsets: 1) unfractionated, peripheral, small (resting), or large (activated) CD4+ T cells; 2) fractionated, peripheral, small, or large, CD45RBhigh or CD45RBlow CD4+ T cells; and 3) peripheral IL-12-unresponsive CD4+ T cells from STAT-4-deficient mice. The adoptive transfer into SCID host of comparable numbers of CD4+ T cells was used to assess the colitis-inducing potency of these subsets. Small CD45RBhigh CD4+ T lymphocytes and activated CD4+ T blasts induced early (6-12 wk posttransfer) and severe disease, while small resting and unfractionated CD4+ T cells or CD45RBlow T lymphocytes induced a late-onset disease 12-16 wk posttransfer. SCID mice transplanted with STAT-4-/- CD4+ T cells showed a late-onset IBD manifest > 20 wk posttransfer. In SCID mice with IBD transplanted with IL-12-responsive CD4+ T cells, the colonic lamina propria CD4+ T cells showed a mucosa-seeking memory/effector CD45RBlow Th1 phenotype abundantly producing IFN-gamma and TNF-alpha. In SCID mice transplanted with IL-12-unresponsive STAT-4-/- CD4+ T cells, the colonic lamina propria, mesenteric lymph node, and splenic CD4+ T cells produced very little IFN-gamma but abundant levels of TNF-alpha. The histopathologic appearance of colitis in all transplanted SCID mice was similar. These data indicate that CD45RBhigh and CD45RBlow, IL-12-responsive and IL-12-unresponsive CD4+ T lymphocytes and lymphoblasts have IBD-inducing potential though of varying potency.  (+info)

Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. (5/2435)

The aetiology of the chronic inflammatory bowel diseases-ulcerative colitis and Crohn's disease-as well as 'microscopic colitis'-both collagenous (COC) and lymphocytic colitis (LC)-remains unknown. Autoimmune mechanisms, cytokine polymorphism, commensal bacteria, infectious agents and vascular impairment have all been proposed as playing important roles in the pathogenesis of this spectrum of diseases. A variety of proinflammatory mediators, including tumour necrosis factor alpha, interleukin-1beta, interferon gamma, leukotriene B4 and platelet activating factor, promote the adherence of phagocytes to the venular endothelium and extravasation of these cells into the colonic mucosa. In addition to large amounts of nitric oxide (NO), injurious peroxynitrite may be formed in the epithelium by the inducible nitric oxide synthase (iNOS), which is considered to elicit cytotoxicity by the generation of superoxide with reduced L-arginine availability. In active ulcerative colitis, and to a lesser extent in Crohn's disease, a greatly increased production of NO has been demonstrated by indirect and direct measurements. Surprisingly, even higher rates of production have been observed in COC-a condition which is never associated with injurious inflammation. The latter observation favours the notion that NO promotes mucosal integrity. Further evidence for a protective role of NO in chronic inflammatory bowel disorders is provided by the observation of increased susceptibility to the induction of experi mental colitis in 'knock-out' mice deficient in iNOS. Selective inhibitors of iNOS activity, as well as topical L-arginine, may therefore prove beneficial in inflammatory bowel disease by reducing the production of superoxide by iNOS, while only the former option may be expected to reduce diarrhoea in chronic inflammatory bowel disorders. Clearly, further experimental work needs to be done before testing topical L-arginine in human inflammatory bowel disease.  (+info)

Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease. (6/2435)

BACKGROUND: Inflammatory mediator concentration was found to be increased in active inflammatory bowel disease, and this could be related to an insulin-resistant state. Moreover, glucocorticoids, which are widely used in the treatment of inflammatory bowel disease, are notoriously related to insulin resistance. AIM: To measure body composition, whole body glucose uptake and oxidation in Crohn's disease and ulcerative colitis patients with inactive disease. METHODS: All patients had clinical, ultrasound and biochemical assessment. Body composition was determined by isotopic dilution technique; basal metabolic rate and substrate oxidation were measured by indirect calorimetry. Insulin sensitivity was assessed by the euglycaemic hyperinsulinaemic clamp. Ten patients with inactive Crohn's disease (five males, aged 31.1 +/- 7.0 years) and 10 patients with inactive ulcerative colitis (five males, aged 33.4 +/- 8.8 years) participated in the study. Forty healthy subjects, matched for age and height were used as a control group. RESULTS: Crohn's disease patients showed lower BMI (P < 0.001), fat mass (P < 0.05) and respiratory quotient (P < 0.001) values compared to both ulcerative colitis and control subjects. No difference in peripheral glucose uptake (micromol/kg/min) was found between groups (respectively 42.5 +/- 6.78 in Crohn's disease, 40.2 +/- 8.00 in ulcerative colitis and 41.4 +/- 10.8 in control subjects). Glucose storage and oxidation did not differ between groups. CONCLUSION: Our data showed that inflammatory bowel disease patients in a remission phase of the disease activity had a whole body glucose uptake and oxidation similar to those of control subjects, probably due to fat-free mass preservation and low blood and tissue cytokine concentration.  (+info)

Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies. (7/2435)

BACKGROUND: The therapeutic efficacy of 5-aminosalicylic acid in inflammatory bowel disease may be related to its antioxidant properties. AIM: To compare in vitro the antioxidant effects of conventional drugs (5-aminosalicylic acid, corticosteroids, metronidazole), with new aminosalicylates (4-aminosalicylic acid, balsalazide) and other potential therapies (ascorbate, N-acetylcysteine, glutathione, verapamil). METHODS: Compounds were assessed for efficacy in reducing the in vitro production of reactive oxygen species by cell-free systems (using xanthine/xanthine oxidase, with or without myeloperoxidase) and by colorectal biopsies from patients with ulcerative colitis using luminol-amplified chemiluminescence. RESULTS: 5-aminosalicylic acid and balsalazide were more potent antioxidants than 4-aminosalicylic acid or N-acetyl-5-aminosalicylic acid in cell-free systems. 5-aminosalicylic acid (20 mM) and balsalazide (20 mM) inhibited rectal biopsy chemiluminescence by 93% and 100%, respectively, compared with only 59% inhibition by 4-aminosalicylic acid (20 mM). Hydrocortisone, metronidazole and verapamil had no significant effect on chemiluminescence in any system. Ascorbate (20 mM) inhibited chemiluminescence by 100% in cell-free systems and by 60% in rectal biopsies. N-acetyl cysteine (10 mM), and both oxidized and reduced glutathione (10 mM), completely inhibited chemiluminescence in cell-free systems, but not with rectal biopsies. CONCLUSIONS: The antioxidant effects of compounds varies between cell-free systems and inflamed colorectal biopsies. The effect of drugs on the chemiluminescence produced by these two assay systems is useful for screening potentially new antioxidant treatments for inflammatory bowel disease. Ascorbate seems worth further study as a novel therapy.  (+info)

Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. (8/2435)

BACKGROUND: The beta chemokine monocyte chemotactic protein 3 (MCP-3) has chemoattractant and activating capabilities in monocytes, lymphocytes, eosinophils, and basophils. AIMS: To investigate MCP-3 expression in inflammatory conditions of the human intestinal mucosa. PATIENTS: Forty five colon biopsy specimens from 18 patients with inflammatory bowel disease (IBD; 16 specimens from inflamed and 10 from non-inflamed areas) and 19 control patients were examined. METHODS: Immunohistochemical staining and reverse transcription polymerase chain reaction (RT-PCR) were used for MCP-3 detection in tissue sections. Intestinal epithelial cell lines (HT-29, Caco-2, T-84) were stimulated with interleukin (IL) 1beta, IL-6, and tumour necrosis factor alpha (TNF-alpha) and examined for MCP-3 protein and mRNA expression using immunocytochemistry and RT-PCR, respectively. RESULTS: In tissue sections, MCP-3 protein was detected predominantly in epithelial cells, both in patients with IBD and in controls. MCP-3 staining was particularly pronounced at sites of active mucosal inflammation. The intensity of MCP-3 staining was positively correlated with the extent of epithelial destruction. In intestinal epithelial cell lines, MCP-3 mRNA was expressed, whereas MCP-3 protein was not consistently detected. CONCLUSIONS: Our data show that MCP-3 protein is present in normal and inflamed intestinal tissue. MCP-3 production is substantially enhanced in areas of active inflammation, suggesting an immunoregulatory role of MCP-3 in intestinal inflammation.  (+info)

Inflammatory Bowel Diseases (IBD) are a group of chronic inflammatory conditions primarily affecting the gastrointestinal tract. The two main types of IBD are Crohn's disease and ulcerative colitis.

Crohn's disease can cause inflammation in any part of the digestive system, from the mouth to the anus, but it most commonly affects the lower part of the small intestine (the ileum) and/or the colon. The inflammation caused by Crohn's disease often spreads deep into the layers of affected bowel tissue.

Ulcerative colitis, on the other hand, is limited to the colon, specifically the innermost lining of the colon. It causes long-lasting inflammation and sores (ulcers) in the lining of the large intestine (colon) and rectum.

Symptoms can vary depending on the severity and location of inflammation but often include abdominal pain, diarrhea, fatigue, weight loss, and reduced appetite. IBD is not the same as irritable bowel syndrome (IBS), which is a functional gastrointestinal disorder.

The exact cause of IBD remains unknown, but it's thought to be a combination of genetic factors, an abnormal immune response, and environmental triggers. There is no cure for IBD, but treatments can help manage symptoms and reduce inflammation, potentially leading to long-term remission.

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the lining of the large intestine (colon) and rectum. In ulcerative colitis, the lining of the colon becomes inflamed and develops ulcers or open sores that produce pus and mucous. The symptoms of ulcerative colitis include diarrhea, abdominal pain, and rectal bleeding.

The exact cause of ulcerative colitis is not known, but it is thought to be related to an abnormal immune response in which the body's immune system attacks the cells in the digestive tract. The inflammation can be triggered by environmental factors such as diet, stress, and infections.

Ulcerative colitis is a chronic condition that can cause symptoms ranging from mild to severe. It can also lead to complications such as anemia, malnutrition, and colon cancer. There is no cure for ulcerative colitis, but treatment options such as medications, lifestyle changes, and surgery can help manage the symptoms and prevent complications.

Crohn's disease is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, from the mouth to the anus. It is characterized by chronic inflammation of the digestive tract, which can lead to symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and malnutrition.

The specific causes of Crohn's disease are not fully understood, but it is believed to be related to a combination of genetic, environmental, and immune system factors. The disease can affect people of any age, but it is most commonly diagnosed in young adults between the ages of 15 and 35.

There is no cure for Crohn's disease, but treatments such as medications, lifestyle changes, and surgery can help manage symptoms and prevent complications. Treatment options depend on the severity and location of the disease, as well as the individual patient's needs and preferences.

Colitis is a medical term that refers to inflammation of the inner lining of the colon or large intestine. The condition can cause symptoms such as diarrhea, abdominal cramps, and urgency to have a bowel movement. Colitis can be caused by a variety of factors, including infections, inflammatory bowel disease (such as Crohn's disease or ulcerative colitis), microscopic colitis, ischemic colitis, and radiation therapy. The specific symptoms and treatment options for colitis may vary depending on the underlying cause.

The intestinal mucosa is the innermost layer of the intestines, which comes into direct contact with digested food and microbes. It is a specialized epithelial tissue that plays crucial roles in nutrient absorption, barrier function, and immune defense. The intestinal mucosa is composed of several cell types, including absorptive enterocytes, mucus-secreting goblet cells, hormone-producing enteroendocrine cells, and immune cells such as lymphocytes and macrophages.

The surface of the intestinal mucosa is covered by a single layer of epithelial cells, which are joined together by tight junctions to form a protective barrier against harmful substances and microorganisms. This barrier also allows for the selective absorption of nutrients into the bloodstream. The intestinal mucosa also contains numerous lymphoid follicles, known as Peyer's patches, which are involved in immune surveillance and defense against pathogens.

In addition to its role in absorption and immunity, the intestinal mucosa is also capable of producing hormones that regulate digestion and metabolism. Dysfunction of the intestinal mucosa can lead to various gastrointestinal disorders, such as inflammatory bowel disease, celiac disease, and food allergies.

The colon, also known as the large intestine, is a part of the digestive system in humans and other vertebrates. It is an organ that eliminates waste from the body and is located between the small intestine and the rectum. The main function of the colon is to absorb water and electrolytes from digested food, forming and storing feces until they are eliminated through the anus.

The colon is divided into several regions, including the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, rectum, and anus. The walls of the colon contain a layer of muscle that helps to move waste material through the organ by a process called peristalsis.

The inner surface of the colon is lined with mucous membrane, which secretes mucus to lubricate the passage of feces. The colon also contains a large population of bacteria, known as the gut microbiota, which play an important role in digestion and immunity.

Mesalamine is an anti-inflammatory drug that is primarily used to treat inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease. It works by reducing inflammation in the intestines, which can help alleviate symptoms like diarrhea, abdominal pain, and rectal bleeding.

Mesalamine is available in various forms, including oral tablets, capsules, suppositories, and enemas. The specific formulation and dosage may vary depending on the severity and location of the inflammation in the gut.

The drug's anti-inflammatory effects are thought to be mediated by its ability to inhibit the activity of certain enzymes involved in the inflammatory response, such as cyclooxygenase and lipoxygenase. By reducing inflammation, mesalamine can help promote healing and prevent recurrences of IBD symptoms.

It's important to note that mesalamine may cause side effects, including headache, nausea, vomiting, and abdominal pain. In rare cases, it may also cause more serious side effects like kidney damage or allergic reactions. Patients should talk to their healthcare provider about the potential risks and benefits of taking mesalamine.

Dextran sulfate is a type of polysaccharide (a complex carbohydrate) that is made up of repeating units of the sugar dextran, which has been sulfonated (introduced with a sulfonic acid group). It is commonly used as a molecular weight standard in laboratory research and can also be found in some medical products.

In medicine, dextran sulfate is often used as a treatment for hemodialysis patients to prevent the formation of blood clots in the dialyzer circuit. It works by binding to and inhibiting the activity of certain clotting factors in the blood. Dextran sulfate may also have anti-inflammatory effects, and it has been studied as a potential treatment for conditions such as inflammatory bowel disease and hepatitis.

It is important to note that dextran sulfate can have side effects, including allergic reactions, low blood pressure, and bleeding. It should be used under the close supervision of a healthcare professional.

Azathioprine is an immunosuppressive medication that is used to prevent the rejection of transplanted organs and to treat autoimmune diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease. It works by suppressing the activity of the immune system, which helps to reduce inflammation and prevent the body from attacking its own tissues.

Azathioprine is a prodrug that is converted into its active form, 6-mercaptopurine, in the body. This medication can have significant side effects, including decreased white blood cell count, increased risk of infection, and liver damage. It may also increase the risk of certain types of cancer, particularly skin cancer and lymphoma.

Healthcare professionals must carefully monitor patients taking azathioprine for these potential side effects. They may need to adjust the dosage or stop the medication altogether if serious side effects occur. Patients should also take steps to reduce their risk of infection and skin cancer, such as practicing good hygiene, avoiding sun exposure, and using sunscreen.

Gastrointestinal agents are a class of pharmaceutical drugs that affect the gastrointestinal (GI) tract, which includes the organs involved in digestion such as the mouth, esophagus, stomach, small intestine, large intestine, and anus. These agents can have various effects on the GI tract, including:

1. Increasing gastric motility (promoting bowel movements) - laxatives, prokinetics
2. Decreasing gastric motility (reducing bowel movements) - antidiarrheal agents
3. Neutralizing gastric acid - antacids
4. Reducing gastric acid secretion - H2-blockers, proton pump inhibitors
5. Protecting the mucosal lining of the GI tract - sucralfate, misoprostol
6. Relieving symptoms associated with GI disorders such as bloating, abdominal pain, and nausea - antispasmodics, antiemetics

Examples of gastrointestinal agents include:

* Laxatives (e.g., psyllium, docusate)
* Prokinetics (e.g., metoclopramide)
* Antacids (e.g., calcium carbonate, aluminum hydroxide)
* H2-blockers (e.g., ranitidine, famotidine)
* Proton pump inhibitors (e.g., omeprazole, lansoprazole)
* Sucralfate
* Misoprostol
* Antispasmodics (e.g., hyoscyamine, dicyclomine)
* Antiemetics (e.g., ondansetron, promethazine)

It is important to note that gastrointestinal agents can have both therapeutic and adverse effects, and their use should be based on a careful evaluation of the patient's condition and medical history.

I'm sorry for any confusion, but "Trinitrobenzenesulfonic Acid" is not a medical term. It is an organic compound used in industrial and research applications, such as a reagent in chemical reactions. Its formula is C6H3N3O9S. If you have any questions about chemical compounds or scientific terms, I'd be happy to try to help with those!

Aminosalicylic acids are a group of medications that contain a chemical structure related to salicylic acid, which is the active ingredient in aspirin. These medications are primarily used to treat inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. The most common aminosalicylates used for IBD include mesalamine, sulfasalazine, and olsalazine.

These drugs work by reducing the production of chemicals in the body that cause inflammation in the lining of the intestines. By decreasing inflammation, they can help alleviate symptoms such as diarrhea, abdominal pain, and rectal bleeding associated with IBD. Additionally, aminosalicylates may also have a protective effect on the lining of the intestines, helping to prevent further damage.

Aminosalicylates are available in various forms, including tablets, capsules, suppositories, and enemas, depending on the specific medication and the location of the inflammation within the digestive tract. While these medications are generally well-tolerated, they can cause side effects such as headache, nausea, vomiting, and abdominal pain in some individuals. It is essential to follow the prescribing physician's instructions carefully when taking aminosalicylates to ensure their safe and effective use.

6-Mercaptopurine (6-MP) is a medication used primarily in the treatment of cancer, specifically acute lymphoblastic leukemia (ALL), and to prevent rejection in organ transplantation. It is an antimetabolite that works by interfering with the synthesis of DNA and RNA, thereby inhibiting cell division and growth.

6-MP is a prodrug, meaning it requires metabolic activation in the body to exert its therapeutic effects. Once absorbed, 6-MP is converted into several active metabolites, including thioguanine nucleotides (TGN), which are incorporated into DNA and RNA, leading to cytotoxicity and cell death.

Common side effects of 6-MP include nausea, vomiting, diarrhea, mouth sores, and increased susceptibility to infections. Long-term use of the medication can also lead to liver toxicity, pancreatitis, and anemia. Regular monitoring of blood counts, liver function tests, and TGN levels is necessary during treatment with 6-MP to minimize potential side effects and ensure safe and effective dosing.

Sulfasalazine is defined as a medication that is commonly used to treat inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn's disease. It is also used in the treatment of rheumatoid arthritis. Sulfasalazine has an anti-inflammatory effect, which helps to reduce inflammation in the gut or joints.

The medication contains two components: sulfapyridine and 5-aminosalicylic acid (5-ASA). The sulfapyridine component is an antibiotic that may help to reduce the number of harmful bacteria in the gut, while the 5-ASA component is responsible for the anti-inflammatory effect.

Sulfasalazine works by being broken down into its two components after it is ingested. The 5-ASA component then acts directly on the lining of the gut to reduce inflammation, while the sulfapyridine component is absorbed into the bloodstream and excreted in the urine.

Common side effects of sulfasalazine include nausea, vomiting, heartburn, headache, and loss of appetite. Less common but more serious side effects may include allergic reactions, liver or kidney problems, and blood disorders. It is important to take sulfasalazine exactly as directed by a healthcare provider and to report any concerning symptoms promptly.

The intestines, also known as the bowel, are a part of the digestive system that extends from the stomach to the anus. They are responsible for the further breakdown and absorption of nutrients from food, as well as the elimination of waste products. The intestines can be divided into two main sections: the small intestine and the large intestine.

The small intestine is a long, coiled tube that measures about 20 feet in length and is lined with tiny finger-like projections called villi, which increase its surface area and enhance nutrient absorption. The small intestine is where most of the digestion and absorption of nutrients takes place.

The large intestine, also known as the colon, is a wider tube that measures about 5 feet in length and is responsible for absorbing water and electrolytes from digested food, forming stool, and eliminating waste products from the body. The large intestine includes several regions, including the cecum, colon, rectum, and anus.

Together, the intestines play a critical role in maintaining overall health and well-being by ensuring that the body receives the nutrients it needs to function properly.

Ileitis is a medical term that refers to inflammation of the ileum, which is the last part of the small intestine. The condition can have various causes, including infections, autoimmune disorders, and inflammatory bowel diseases such as Crohn's disease.

The symptoms of ileitis may include abdominal pain, diarrhea, fever, weight loss, and nausea or vomiting. The diagnosis of ileitis typically involves a combination of medical history, physical examination, laboratory tests, and imaging studies such as CT scans or MRI.

Treatment for ileitis depends on the underlying cause of the inflammation. In cases of infectious ileitis, antibiotics may be used to treat the infection. For autoimmune or inflammatory causes, medications that suppress the immune system may be necessary to reduce inflammation and manage symptoms.

In severe cases of ileitis, surgery may be required to remove damaged portions of the intestine or to drain abscesses. It is important to seek medical attention if you experience symptoms of ileitis, as early diagnosis and treatment can help prevent complications and improve outcomes.

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent abdominal pain, bloating, and altered bowel habits in the absence of any structural or biochemical abnormalities. The symptoms can vary from person to person, ranging from mild to severe.

The exact cause of IBS is not known, but it's thought to involve a combination of factors such as muscle contractions in the intestine, abnormalities in the nervous system, inflammation in the intestines, severe infection, or changes in bacteria in the gut.

It's important to note that while IBS can cause great discomfort and distress, it does not lead to serious complications such as changes in bowel tissue or increased risk of colorectal cancer. However, it can significantly affect a person's quality of life and daily activities.

NOD2 (Nucleotide-binding Oligomerization Domain-containing protein 2) signaling adaptor protein, also known as CARD15 (Caspase Recruitment Domain-containing protein 15), is a crucial intracellular pattern recognition receptor (PRR) that plays an essential role in the innate immune response. NOD2 is primarily expressed in monocytes, macrophages, dendritic cells, and intestinal epithelial cells.

NOD2 signaling adaptor protein contains two caspase recruitment domains (CARD), a nucleotide-binding oligomerization domain (NOD), and multiple leucine-rich repeats (LRR). The LRR region is responsible for recognizing and binding to pathogen-associated molecular patterns (PAMPs) derived from bacterial cell walls, such as muramyl dipeptide (MDP). Upon recognition of MDP, NOD2 undergoes oligomerization through its NOD domain, which leads to the recruitment of receptor-interacting protein kinase 2 (RIPK2) via CARD-CARD interactions. This interaction results in the activation of downstream signaling pathways, including nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs), which ultimately induce the expression of proinflammatory cytokines, chemokines, and antimicrobial peptides.

Dysregulation or mutations in NOD2 signaling adaptor protein have been implicated in several inflammatory diseases, such as Crohn's disease, Blau syndrome, and susceptibility to certain mycobacterial infections.

Intestinal diseases refer to a wide range of conditions that affect the function or structure of the small intestine, large intestine (colon), or both. These diseases can cause various symptoms such as abdominal pain, diarrhea, constipation, bloating, nausea, vomiting, and weight loss. They can be caused by infections, inflammation, genetic disorders, or other factors. Some examples of intestinal diseases include inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, Crohn's disease, ulcerative colitis, and intestinal infections. The specific medical definition may vary depending on the context and the specific condition being referred to.

Pyoderma gangrenosum is a rare, inflammatory skin condition that typically begins as a small pustule or blister, which then rapidly progresses to form painful ulcers with a characteristic violaceous (bluish-purple) undermined border. The etiology of pyoderma gangrenosum is not entirely clear, but it's often associated with an underlying systemic disease, such as inflammatory bowel disease, rheumatoid arthritis, or hematologic disorders.

The pathophysiology of pyoderma gangrenosum involves a dysregulated immune response and neutrophil-mediated tissue damage. Diagnosis is often based on the clinical presentation and exclusion of other conditions with similar lesions. Treatment typically includes systemic immunosuppressive therapy, such as corticosteroids, cyclosporine, or biologic agents, along with local wound care to promote healing and prevent infection.

It's important to note that pyoderma gangrenosum can be a challenging condition to manage, and a multidisciplinary approach involving dermatologists, internists, and surgeons may be necessary for optimal care.

Probiotics are defined by the World Health Organization (WHO) as "live microorganisms which when administered in adequate amounts confer a health benefit on the host." They are often referred to as "good" or "friendly" bacteria because they help keep your gut healthy. Probiotics are naturally found in certain foods such as fermented foods like yogurt, sauerkraut, and some cheeses, or they can be taken as dietary supplements.

The most common groups of probiotics are lactic acid bacteria (like Lactobacillus) and bifidobacteria. They can help restore the balance of bacteria in your gut when it's been disrupted by things like illness, medication (such as antibiotics), or poor diet. Probiotics have been studied for their potential benefits in a variety of health conditions, including digestive issues, skin conditions, and even mental health disorders, although more research is needed to fully understand their effects and optimal uses.

Anti-inflammatory agents are a class of drugs or substances that reduce inflammation in the body. They work by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, which are released during an immune response and contribute to symptoms like pain, swelling, redness, and warmth.

There are two main types of anti-inflammatory agents: steroidal and nonsteroidal. Steroidal anti-inflammatory drugs (SAIDs) include corticosteroids, which mimic the effects of hormones produced by the adrenal gland. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a larger group that includes both prescription and over-the-counter medications, such as aspirin, ibuprofen, naproxen, and celecoxib.

While both types of anti-inflammatory agents can be effective in reducing inflammation and relieving symptoms, they differ in their mechanisms of action, side effects, and potential risks. Long-term use of NSAIDs, for example, can increase the risk of gastrointestinal bleeding, kidney damage, and cardiovascular events. Corticosteroids can have significant side effects as well, particularly with long-term use, including weight gain, mood changes, and increased susceptibility to infections.

It's important to use anti-inflammatory agents only as directed by a healthcare provider, and to be aware of potential risks and interactions with other medications or health conditions.

The Leukocyte L1 Antigen Complex, also known as CD58 or LFA-3 (Lymphocyte Function-Associated Antigen 3), is not a single entity but rather a glycoprotein found on the surface of various cells in the human body, including leukocytes (white blood cells). It plays a crucial role in the immune system's response by interacting with the CD2 receptor on T-cells and natural killer (NK) cells. This interaction helps facilitate cell-to-cell adhesion and activation of T-cells, which are essential for an effective immune response against infections and cancer.

The Leukocyte L1 Antigen Complex is often targeted by certain viruses to evade the host's immune system. For example, some strains of HIV (Human Immunodeficiency Virus) can downregulate the expression of this protein on infected cells, making it harder for the immune system to recognize and eliminate them.

It is important to note that while "Leukocyte L1 Antigen Complex" refers to a specific cell surface protein, CD58 or LFA-3 are alternative names used in the scientific literature to refer to this same protein.

The rectum is the lower end of the digestive tract, located between the sigmoid colon and the anus. It serves as a storage area for feces before they are eliminated from the body. The rectum is about 12 cm long in adults and is surrounded by layers of muscle that help control defecation. The mucous membrane lining the rectum allows for the detection of stool, which triggers the reflex to have a bowel movement.

Non-steroidal anti-inflammatory agents (NSAIDs) are a class of medications that reduce pain, inflammation, and fever. They work by inhibiting the activity of cyclooxygenase (COX) enzymes, which are involved in the production of prostaglandins, chemicals that contribute to inflammation and cause blood vessels to dilate and become more permeable, leading to symptoms such as pain, redness, warmth, and swelling.

NSAIDs are commonly used to treat a variety of conditions, including arthritis, muscle strains and sprains, menstrual cramps, headaches, and fever. Some examples of NSAIDs include aspirin, ibuprofen, naproxen, and celecoxib.

While NSAIDs are generally safe and effective when used as directed, they can have side effects, particularly when taken in large doses or for long periods of time. Common side effects include stomach ulcers, gastrointestinal bleeding, and increased risk of heart attack and stroke. It is important to follow the recommended dosage and consult with a healthcare provider if you have any concerns about using NSAIDs.

The gastrointestinal (GI) tract, also known as the digestive tract, is a continuous tube that starts at the mouth and ends at the anus. It is responsible for ingesting, digesting, absorbing, and excreting food and waste materials. The GI tract includes the mouth, esophagus, stomach, small intestine (duodenum, jejunum, ileum), large intestine (cecum, colon, rectum, anus), and accessory organs such as the liver, gallbladder, and pancreas. The primary function of this system is to process and extract nutrients from food while also protecting the body from harmful substances, pathogens, and toxins.

Immunosuppressive agents are medications that decrease the activity of the immune system. They are often used to prevent the rejection of transplanted organs and to treat autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. These drugs work by interfering with the immune system's normal responses, which helps to reduce inflammation and damage to tissues. However, because they suppress the immune system, people who take immunosuppressive agents are at increased risk for infections and other complications. Examples of immunosuppressive agents include corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, tacrolimus, and sirolimus.

Gastroenterology is a branch of medicine that deals with the study, diagnosis, management, and treatment of disorders and diseases of the digestive system, also known as the gastrointestinal (GI) tract. This includes the esophagus, stomach, small intestine, large intestine (colon), liver, pancreas, gallbladder, and bile ducts.

Physicians who specialize in this field are called gastroenterologists. They undergo extensive training in internal medicine and then complete a fellowship in gastroenterology, where they gain expertise in using various diagnostic techniques such as endoscopy, colonoscopy, and radiologic imaging to evaluate GI tract disorders.

Gastroenterologists treat a wide range of conditions affecting the digestive system, including but not limited to:

1. Gastroesophageal reflux disease (GERD)
2. Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis
3. Irritable bowel syndrome (IBS)
4. Celiac disease
5. Hepatitis and other liver diseases
6. Pancreatic disorders, such as pancreatitis
7. Gastrointestinal cancers, like colon, rectal, and esophageal cancer
8. Functional gastrointestinal disorders (FGIDs), which include chronic abdominal pain, bloating, and difficulty with bowel movements

By focusing on the prevention, diagnosis, and treatment of digestive diseases, gastroenterologists play a crucial role in maintaining overall health and well-being for their patients.

The ileum is the third and final segment of the small intestine, located between the jejunum and the cecum (the beginning of the large intestine). It plays a crucial role in nutrient absorption, particularly for vitamin B12 and bile salts. The ileum is characterized by its thin, lined walls and the presence of Peyer's patches, which are part of the immune system and help surveil for pathogens.

A colonoscopy is a medical procedure used to examine the large intestine, also known as the colon and rectum. It is performed using a flexible tube with a tiny camera on the end, called a colonoscope, which is inserted into the rectum and gently guided through the entire length of the colon.

The procedure allows doctors to visually inspect the lining of the colon for any abnormalities such as polyps, ulcers, inflammation, or cancer. If any polyps are found during the procedure, they can be removed immediately using special tools passed through the colonoscope. Colonoscopy is an important tool in the prevention and early detection of colorectal cancer, which is one of the leading causes of cancer-related deaths worldwide.

Patients are usually given a sedative to help them relax during the procedure, which is typically performed on an outpatient basis in a hospital or clinic setting. The entire procedure usually takes about 30-60 minutes to complete, although patients should plan to spend several hours at the medical facility for preparation and recovery.

"Helicobacter hepaticus" is a gram-negative, spiral-shaped bacterium that colonizes the liver of various animals, including primates. It was initially identified in 1992 and has been associated with chronic active hepatitis and hepatic adenocarcinoma (liver cancer) in mice. While its role in human disease is not fully understood, some studies have suggested a possible link between H. hepaticus infection and liver inflammation or cancer in humans. However, more research is needed to confirm this association and establish the clinical significance of H. hepaticus in human health.

Proctitis is a medical condition that refers to inflammation of the lining of the rectum, which is the lower end of the colon. The symptoms of proctitis may include rectal pain, discomfort, or a feeling of fullness; rectal bleeding, often in the form of mucus or blood; diarrhea; and urgency to have a bowel movement.

Proctitis can be caused by a variety of factors, including infections (such as sexually transmitted infections, foodborne illnesses, or inflammatory bowel diseases like Crohn's disease or ulcerative colitis), radiation therapy, trauma, or autoimmune disorders. The diagnosis of proctitis typically involves a physical examination, medical history, and sometimes endoscopic procedures to visualize the rectum and take tissue samples for further testing. Treatment depends on the underlying cause but may include antibiotics, anti-inflammatory medications, or other therapies.

Sclerosing cholangitis is a chronic progressive disease characterized by inflammation and scarring (fibrosis) of the bile ducts, leading to their narrowing or obstruction. This results in impaired bile flow from the liver to the small intestine, which can cause damage to the liver cells and eventually result in cirrhosis and liver failure.

The condition often affects both the intrahepatic (within the liver) and extrahepatic (outside the liver) bile ducts. The exact cause of sclerosing cholangitis is not known, but it is believed to involve an autoimmune response, genetic predisposition, and environmental factors.

Symptoms of sclerosing cholangitis may include jaundice (yellowing of the skin and eyes), itching, abdominal pain, fatigue, weight loss, dark urine, and light-colored stools. The diagnosis is typically made through imaging tests such as magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP), which can visualize the bile ducts and detect any abnormalities.

Treatment for sclerosing cholangitis is aimed at managing symptoms, preventing complications, and slowing down the progression of the disease. This may include medications to relieve itching, antibiotics to treat infections, and drugs to reduce inflammation and improve bile flow. In severe cases, a liver transplant may be necessary.

A metagenome is the collective genetic material contained within a sample taken from a specific environment, such as soil or water, or within a community of organisms, like the microbiota found in the human gut. It includes the genomes of all the microorganisms present in that environment or community, including bacteria, archaea, fungi, viruses, and other microbes, whether they can be cultured in the lab or not. By analyzing the metagenome, scientists can gain insights into the diversity, abundance, and functional potential of the microbial communities present in that environment.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Inflammation is a complex biological response of tissues to harmful stimuli, such as pathogens, damaged cells, or irritants. It is characterized by the following signs: rubor (redness), tumor (swelling), calor (heat), dolor (pain), and functio laesa (loss of function). The process involves the activation of the immune system, recruitment of white blood cells, and release of inflammatory mediators, which contribute to the elimination of the injurious stimuli and initiation of the healing process. However, uncontrolled or chronic inflammation can also lead to tissue damage and diseases.

Spondylarthropathies is a term used to describe a group of interrelated inflammatory diseases that primarily affect the joints of the spine (vertebral column) and the sites where the ligaments and tendons attach to the bones (entheses). These conditions also often have associations with extra-articular features, such as skin, eye, and intestinal manifestations. The most common spondylarthropathies are ankylosing spondylitis, psoriatic arthritis, reactive arthritis (formerly known as Reiter's syndrome), enteropathic arthritis (associated with inflammatory bowel disease), and undifferentiated spondyloarthropathies.

The primary hallmark of these conditions is enthesitis, which is an inflammation at the sites where ligaments or tendons attach to bones. This can lead to pain, stiffness, and limited mobility in the affected areas, particularly in the spine and sacroiliac joints (the joints that connect the base of the spine to the pelvis).

Spondylarthropathies have a strong genetic association with the human leukocyte antigen B27 (HLA-B27) gene. However, not all individuals with this gene will develop spondylarthropathies, and many people without the gene can still be affected by these conditions.

Early diagnosis and appropriate treatment of spondylarthropathies are essential to help manage symptoms, prevent joint damage, and maintain mobility and quality of life. Treatment options typically include a combination of medications, physical therapy, and lifestyle modifications.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

The large intestine, also known as the colon, is the lower part of the gastrointestinal tract that extends from the cecum, where it joins the small intestine, to the anus. It is called "large" because it has a larger diameter compared to the small intestine and is responsible for several important functions in the digestive process.

The large intestine measures about 1.5 meters (5 feet) long in adults and consists of four main regions: the ascending colon, transverse colon, descending colon, and sigmoid colon. The primary function of the large intestine is to absorb water and electrolytes from undigested food materials, compact the remaining waste into feces, and store it until it is eliminated through defecation.

The large intestine also contains a diverse population of bacteria that aid in digestion by breaking down complex carbohydrates, producing vitamins like vitamin K and some B vitamins, and competing with harmful microorganisms to maintain a healthy balance within the gut. Additionally, the large intestine plays a role in immune function and helps protect the body from pathogens through the production of mucus, antimicrobial substances, and the activation of immune cells.

Gastrointestinal diseases refer to a group of conditions that affect the gastrointestinal (GI) tract, which includes the organs from the mouth to the anus, responsible for food digestion, absorption, and elimination of waste. These diseases can affect any part of the GI tract, causing various symptoms such as abdominal pain, bloating, diarrhea, constipation, nausea, vomiting, and weight loss.

Common gastrointestinal diseases include:

1. Gastroesophageal reflux disease (GERD) - a condition where stomach acid flows back into the esophagus, causing heartburn and other symptoms.
2. Peptic ulcers - sores that develop in the lining of the stomach or duodenum, often caused by bacterial infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
3. Inflammatory bowel disease (IBD) - a group of chronic inflammatory conditions of the intestine, including Crohn's disease and ulcerative colitis.
4. Irritable bowel syndrome (IBS) - a functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits.
5. Celiac disease - an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine.
6. Diverticular disease - a condition that affects the colon, causing diverticula (small pouches) to form and potentially become inflamed or infected.
7. Constipation - a common gastrointestinal symptom characterized by infrequent bowel movements, hard stools, and difficulty passing stools.
8. Diarrhea - a common gastrointestinal symptom characterized by loose, watery stools and frequent bowel movements.
9. Food intolerances and allergies - adverse reactions to specific foods or food components that can cause various gastrointestinal symptoms.
10. Gastrointestinal infections - caused by bacteria, viruses, parasites, or fungi that can lead to a range of symptoms, including diarrhea, vomiting, and abdominal pain.

Tumor Necrosis Factor-alpha (TNF-α) is a cytokine, a type of small signaling protein involved in immune response and inflammation. It is primarily produced by activated macrophages, although other cell types such as T-cells, natural killer cells, and mast cells can also produce it.

TNF-α plays a crucial role in the body's defense against infection and tissue injury by mediating inflammatory responses, activating immune cells, and inducing apoptosis (programmed cell death) in certain types of cells. It does this by binding to its receptors, TNFR1 and TNFR2, which are found on the surface of many cell types.

In addition to its role in the immune response, TNF-α has been implicated in the pathogenesis of several diseases, including autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, as well as cancer, where it can promote tumor growth and metastasis.

Therapeutic agents that target TNF-α, such as infliximab, adalimumab, and etanercept, have been developed to treat these conditions. However, these drugs can also increase the risk of infections and other side effects, so their use must be carefully monitored.

Feces are the solid or semisolid remains of food that could not be digested or absorbed in the small intestine, along with bacteria and other waste products. After being stored in the colon, feces are eliminated from the body through the rectum and anus during defecation. Feces can vary in color, consistency, and odor depending on a person's diet, health status, and other factors.

Dysbiosis is a term used to describe an imbalance in the microbiota, or the community of microorganisms, that normally live on and inside the body. These microorganisms include bacteria, viruses, fungi, and other microbes. In a healthy state, these microorganisms exist in a balanced relationship with each other and with their human host. However, when this balance is disrupted, it can lead to an overgrowth of harmful microbes and a decrease in the number of beneficial ones. This imbalance can occur in different parts of the body, such as the gut, skin, or mouth, and can contribute to various health problems.

In medical terms, dysbiosis is often used to describe an alteration in the composition of the gut microbiota that has been associated with a variety of diseases, including inflammatory bowel disease, irritable bowel syndrome, obesity, diabetes, and even some neurological disorders. The exact mechanisms by which dysbiosis contributes to these conditions are not fully understood, but it is thought to involve changes in the metabolic activities of the microbiota, as well as their interactions with the host's immune system.

It's important to note that while dysbiosis has been linked to various health issues, it does not necessarily mean that it is the cause of those conditions. More research is needed to fully understand the role of dysbiosis in human health and disease.

Colonic diseases refer to a group of medical conditions that affect the colon, also known as the large intestine or large bowel. The colon is the final segment of the digestive system, responsible for absorbing water and electrolytes, and storing and eliminating waste products.

Some common colonic diseases include:

1. Inflammatory bowel disease (IBD): This includes conditions such as Crohn's disease and ulcerative colitis, which cause inflammation and irritation in the lining of the digestive tract.
2. Diverticular disease: This occurs when small pouches called diverticula form in the walls of the colon, leading to symptoms such as abdominal pain, bloating, and changes in bowel movements.
3. Colorectal cancer: This is a type of cancer that develops in the colon or rectum, often starting as benign polyps that grow and become malignant over time.
4. Irritable bowel syndrome (IBS): This is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel movements, but without any underlying structural or inflammatory causes.
5. Constipation: This is a common condition characterized by infrequent bowel movements, difficulty passing stools, or both.
6. Infectious colitis: This occurs when the colon becomes infected with bacteria, viruses, or parasites, leading to symptoms such as diarrhea, abdominal cramps, and fever.

Treatment for colonic diseases varies depending on the specific condition and its severity. Treatment options may include medications, lifestyle changes, surgery, or a combination of these approaches.

Mucosal immunity refers to the immune system's defense mechanisms that are specifically adapted to protect the mucous membranes, which line various body openings such as the respiratory, gastrointestinal, and urogenital tracts. These membranes are constantly exposed to foreign substances, including potential pathogens, and therefore require a specialized immune response to maintain homeostasis and prevent infection.

Mucosal immunity is primarily mediated by secretory IgA (SIgA) antibodies, which are produced by B cells in the mucosa-associated lymphoid tissue (MALT). These antibodies can neutralize pathogens and prevent them from adhering to and invading the epithelial cells that line the mucous membranes.

In addition to SIgA, other components of the mucosal immune system include innate immune cells such as macrophages, dendritic cells, and neutrophils, which can recognize and respond to pathogens through pattern recognition receptors (PRRs). T cells also play a role in mucosal immunity, particularly in the induction of cell-mediated immunity against viruses and other intracellular pathogens.

Overall, mucosal immunity is an essential component of the body's defense system, providing protection against a wide range of potential pathogens while maintaining tolerance to harmless antigens present in the environment.

Genetic predisposition to disease refers to an increased susceptibility or vulnerability to develop a particular illness or condition due to inheriting specific genetic variations or mutations from one's parents. These genetic factors can make it more likely for an individual to develop a certain disease, but it does not guarantee that the person will definitely get the disease. Environmental factors, lifestyle choices, and interactions between genes also play crucial roles in determining if a genetically predisposed person will actually develop the disease. It is essential to understand that having a genetic predisposition only implies a higher risk, not an inevitable outcome.

Sulfapyridine is an antibiotic drug that belongs to the class of medications known as sulfonamides or "sulfa drugs." It is used to treat various bacterial infections by interfering with the bacteria's ability to synthesize essential proteins. Sulfapyridine may be used to treat a variety of infections, including urinary tract infections, bronchitis, and traveler's diarrhea.

The medical definition of Sulfapyridine is:

A sulfonamide antibacterial drug with a prolonged action, primarily used for its antimicrobial properties in treating various bacterial infections. It works by inhibiting the bacterial synthesis of folic acid, an essential component for bacterial growth and survival. Sulfapyridine is often combined with other medications, such as pyrimethamine, to enhance its antibacterial effect in specific therapeutic applications.

It's important to note that sulfonamides can cause side effects, including rashes, allergic reactions, and gastrointestinal symptoms. In some cases, more severe adverse reactions may occur, particularly in individuals with a known hypersensitivity to sulfa drugs or those with specific genetic factors. Always consult with a healthcare professional for appropriate use, dosage, and potential side effects of Sulfapyridine or any other medication.

Cytokines are a broad and diverse category of small signaling proteins that are secreted by various cells, including immune cells, in response to different stimuli. They play crucial roles in regulating the immune response, inflammation, hematopoiesis, and cellular communication.

Cytokines mediate their effects by binding to specific receptors on the surface of target cells, which triggers intracellular signaling pathways that ultimately result in changes in gene expression, cell behavior, and function. Some key functions of cytokines include:

1. Regulating the activation, differentiation, and proliferation of immune cells such as T cells, B cells, natural killer (NK) cells, and macrophages.
2. Coordinating the inflammatory response by recruiting immune cells to sites of infection or tissue damage and modulating their effector functions.
3. Regulating hematopoiesis, the process of blood cell formation in the bone marrow, by controlling the proliferation, differentiation, and survival of hematopoietic stem and progenitor cells.
4. Modulating the development and function of the nervous system, including neuroinflammation, neuroprotection, and neuroregeneration.

Cytokines can be classified into several categories based on their structure, function, or cellular origin. Some common types of cytokines include interleukins (ILs), interferons (IFNs), tumor necrosis factors (TNFs), chemokines, colony-stimulating factors (CSFs), and transforming growth factors (TGFs). Dysregulation of cytokine production and signaling has been implicated in various pathological conditions, such as autoimmune diseases, chronic inflammation, cancer, and neurodegenerative disorders.

Enterocolitis is a medical condition that involves inflammation of the small intestine (enteritis) and large intestine (colitis). This condition can affect people of all ages, but it is most commonly seen in infants and young children. The symptoms of enterocolitis may include diarrhea, abdominal cramps, bloating, nausea, vomiting, fever, and dehydration.

There are several types of enterocolitis, including:

1. Infectious Enterocolitis: This type is caused by a bacterial, viral, or parasitic infection in the intestines. Common causes include Salmonella, Shigella, Escherichia coli (E. coli), and norovirus.
2. Antibiotic-Associated Enterocolitis: This type is caused by an overgrowth of harmful bacteria in the intestines following the use of antibiotics that kill off beneficial gut bacteria.
3. Pseudomembranous Enterocolitis: This is a severe form of antibiotic-associated enterocolitis caused by the bacterium Clostridioides difficile (C. diff).
4. Necrotizing Enterocolitis: This is a serious condition that primarily affects premature infants, causing inflammation and damage to the intestinal tissue, which can lead to perforations and sepsis.
5. Ischemic Enterocolitis: This type is caused by reduced blood flow to the intestines, often due to conditions such as mesenteric ischemia or vasculitis.
6. Radiation Enterocolitis: This type occurs as a complication of radiation therapy for cancer treatment, which can damage the intestinal lining and lead to inflammation.
7. Eosinophilic Enterocolitis: This is a rare condition characterized by an excessive buildup of eosinophils (a type of white blood cell) in the intestinal tissue, leading to inflammation and symptoms similar to those seen in inflammatory bowel disease.

Treatment for enterocolitis depends on the underlying cause and severity of the condition. It may include antibiotics, antiparasitic medications, probiotics, or surgery in severe cases.

Peroxidase is a type of enzyme that catalyzes the chemical reaction in which hydrogen peroxide (H2O2) is broken down into water (H2O) and oxygen (O2). This enzymatic reaction also involves the oxidation of various organic and inorganic compounds, which can serve as electron donors.

Peroxidases are widely distributed in nature and can be found in various organisms, including bacteria, fungi, plants, and animals. They play important roles in various biological processes, such as defense against oxidative stress, breakdown of toxic substances, and participation in metabolic pathways.

The peroxidase-catalyzed reaction can be represented by the following chemical equation:

H2O2 + 2e- + 2H+ → 2H2O

In this reaction, hydrogen peroxide is reduced to water, and the electron donor is oxidized. The peroxidase enzyme facilitates the transfer of electrons between the substrate (hydrogen peroxide) and the electron donor, making the reaction more efficient and specific.

Peroxidases have various applications in medicine, industry, and research. For example, they can be used for diagnostic purposes, as biosensors, and in the treatment of wastewater and medical wastes. Additionally, peroxidases are involved in several pathological conditions, such as inflammation, cancer, and neurodegenerative diseases, making them potential targets for therapeutic interventions.

Pouchitis is a condition characterized by inflammation of the ileal pouch, a surgically created reservoir that is connected to the patient's anus in individuals who have undergone proctocolectomy with ileal pouch-anal anastomosis (IPAA). This procedure is often performed in patients with ulcerative colitis or familial adenomatous polyposis.

Pouchitis can present with symptoms such as diarrhea, abdominal cramps, urgency, and fecal incontinence. The exact cause of pouchitis remains unclear, but it is thought to be related to changes in the microbiota or an overactive immune response in the ileal pouch.

The diagnosis of pouchitis typically involves a combination of clinical symptoms, endoscopic findings, and histopathological examination of biopsies taken during endoscopy. Treatment options for pouchitis include antibiotics, anti-inflammatory medications, and probiotics, depending on the severity and frequency of the condition.

Caco-2 cells are a type of human epithelial colorectal adenocarcinoma cell line that is commonly used in scientific research, particularly in the field of drug development and toxicology. These cells are capable of forming a monolayer with tight junctions, which makes them an excellent model for studying intestinal absorption, transport, and metabolism of drugs and other xenobiotic compounds.

Caco-2 cells express many of the transporters and enzymes that are found in the human small intestine, making them a valuable tool for predicting drug absorption and bioavailability in humans. They are also used to study the mechanisms of drug transport across the intestinal epithelium, including passive diffusion and active transport by various transporters.

In addition to their use in drug development, Caco-2 cells are also used to study the toxicological effects of various compounds on human intestinal cells. They can be used to investigate the mechanisms of toxicity, as well as to evaluate the potential for drugs and other compounds to induce intestinal damage or inflammation.

Overall, Caco-2 cells are a widely used and valuable tool in both drug development and toxicology research, providing important insights into the absorption, transport, metabolism, and toxicity of various compounds in the human body.

Tumor Necrosis Factor Ligand Superfamily Member 15 (TNFSF15) is a type II transmembrane protein that belongs to the tumor necrosis factor (TNF) ligand superfamily. It is also known as vascular endothelial growth inhibitor (VEGI), and it plays a role in regulating immune responses, inflammation, and angiogenesis.

TNFSF15 binds to its receptor, TNFRSF25 (also known as DR3 or APO-3), which is expressed on the surface of various cells including T cells, B cells, and dendritic cells. The binding of TNFSF15 to TNFRSF25 leads to the activation of several signaling pathways, including the nuclear factor kappa B (NF-κB) pathway, which regulates the expression of genes involved in immune responses and inflammation.

TNFSF15 has been shown to have both pro-inflammatory and anti-inflammatory effects, depending on the context. It can promote the activation and survival of T cells, as well as the production of cytokines and chemokines that contribute to inflammation. On the other hand, it can also inhibit angiogenesis and tumor growth by inducing apoptosis in endothelial cells and reducing the expression of pro-angiogenic factors.

Abnormalities in TNFSF15 have been implicated in several diseases, including inflammatory bowel disease, rheumatoid arthritis, psoriasis, and cancer. Therefore, TNFSF15 is a potential target for the development of therapies for these conditions.

A colectomy is a surgical procedure in which all or part of the large intestine (colon) is removed. This surgery may be performed to treat or prevent various medical conditions, including colon cancer, inflammatory bowel disease, diverticulitis, and severe obstructions or injuries of the colon.

There are several types of colectomies, depending on how much of the colon is removed:

* Total colectomy: Removal of the entire colon.
* Partial colectomy: Removal of a portion of the colon.
* Hemicolectomy: Removal of one half of the colon.
* Sigmoidectomy: Removal of the sigmoid colon, which is the part of the colon that is closest to the rectum.

After the affected portion of the colon is removed, the remaining ends of the intestine are reconnected, allowing stool to pass through the digestive system as usual. In some cases, a temporary or permanent colostomy may be necessary, in which a surgical opening (stoma) is created in the abdominal wall and the end of the colon is attached to it, allowing stool to be collected in a pouch outside the body.

Colectomies are major surgeries that require general anesthesia and hospitalization. The recovery time can vary depending on the type of colectomy performed and the individual's overall health, but typically ranges from several weeks to a few months. Complications of colectomy may include bleeding, infection, leakage from the surgical site, bowel obstruction, and changes in bowel habits or function.

Interleukin-10 (IL-10) is an anti-inflammatory cytokine that plays a crucial role in the modulation of immune responses. It is produced by various cell types, including T cells, macrophages, and dendritic cells. IL-10 inhibits the production of pro-inflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-8, and IL-12, and downregulates the expression of costimulatory molecules on antigen-presenting cells. This results in the suppression of T cell activation and effector functions, which ultimately helps to limit tissue damage during inflammation and promote tissue repair. Dysregulation of IL-10 has been implicated in various pathological conditions, including chronic infections, autoimmune diseases, and cancer.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Antineutrophil cytoplasmic antibodies (ANCAs) are a type of autoantibody that specifically target certain proteins in the cytoplasm of neutrophils, which are a type of white blood cell. These antibodies are associated with several types of vasculitis, which is inflammation of the blood vessels.

There are two main types of ANCAs: perinuclear ANCAs (p-ANCAs) and cytoplasmic ANCAs (c-ANCAs). p-ANCAs are directed against myeloperoxidase, a protein found in neutrophil granules, while c-ANCAs target proteinase 3, another protein found in neutrophil granules.

The presence of ANCAs in the blood can indicate an increased risk for developing certain types of vasculitis, such as granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA), and microscopic polyangiitis (MPA). ANCA testing is often used in conjunction with other clinical findings to help diagnose and manage these conditions.

It's important to note that while the presence of ANCAs can indicate an increased risk for vasculitis, not everyone with ANCAs will develop the condition. Additionally, ANCAs can also be found in some individuals without any associated disease, so their presence should be interpreted in the context of other clinical findings.

The hygiene hypothesis is not a formally recognized medical definition, but rather a term used to describe a proposed explanation for the increase in allergic and autoimmune diseases in developed countries. The hypothesis suggests that early childhood exposure to microorganisms and certain infectious agents can help mature and regulate the immune system, reducing the risk of developing these conditions later in life.

In modern, highly sanitized environments, children may not be exposed to as many microbes during their formative years, leading to an overactive immune response that can manifest as allergies or autoimmune disorders. It's important to note that this is a theoretical concept and there is ongoing research to better understand the relationship between early-life exposures, the immune system, and the development of allergic and autoimmune diseases.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Proctocolitis is a medical condition that refers to inflammation of both the rectum (proctitis) and the colon (colitis). It can cause symptoms such as diarrhea, abdominal cramps, and urgency to have a bowel movement. The inflammation can be caused by various factors, including infections, immune-mediated disorders, or irritants. In some cases, the specific cause of proctocolitis may not be identified (known as idiopathic proctocolitis). Treatment for proctocolitis depends on the underlying cause and may include medications to reduce inflammation, manage symptoms, and treat any underlying infections.

Ischemic colitis is a condition characterized by inflammation of the large intestine (colon) due to reduced blood flow to the area. This reduction in blood flow, also known as ischemia, can be caused by various factors such as narrowing or blockage of the blood vessels that supply the colon, low blood pressure, or certain medications.

Symptoms of ischemic colitis may include sudden abdominal pain, bloody diarrhea, nausea, vomiting, and fever. In severe cases, it can lead to tissue death, perforation of the colon, and sepsis. Treatment typically involves supportive care such as fluid replacement, bowel rest, and antibiotics. In some cases, surgery may be necessary to remove damaged tissue or restore blood flow to the area.

Paneth cells are specialized epithelial cells located in the small intestine, specifically in the crypts of Lieberkühn. They play an essential role in the immune function and maintenance of the intestinal environment. Paneth cells are characterized by their large, granulated secretory vesicles that contain antimicrobial peptides and proteins, such as defensins and lysozyme. These substances help to control the growth of bacteria in the small intestine and maintain a balanced microbiota. Additionally, Paneth cells secrete other factors that support the function and survival of stem cells located in the crypts. They are also involved in the inflammatory response by producing cytokines and chemokines, which help to recruit immune cells to the site of infection or injury.

Restorative proctocolectomy, also known as ileal pouch-anal anastomosis (IPAA), is a surgical procedure used to treat ulcerative colitis and familial adenomatous polyposis. This procedure involves the removal of the colon, rectum, and anal canal while preserving the sphincter muscles that control fecal continence.

After removing the diseased tissues, the surgeon creates a pouch from the end of the small intestine (ileum) and attaches it to the anus, restoring the continuity of the gastrointestinal tract. The pouch serves as a reservoir for stool, allowing for more normal bowel movements compared to having a permanent ileostomy.

Restorative proctocolectomy can be performed in one or two stages, depending on the patient's condition and the surgeon's preference. In the two-stage procedure, an initial total colectomy with ileostomy is performed, followed by the creation of the pouch and closure of the ileostomy in a second operation. The single-stage procedure involves removing the colon, creating the pouch, and performing the anastomosis in one surgical setting.

While restorative proctocolectomy significantly improves quality of life for many patients with ulcerative colitis and familial adenomatous polyposis, potential complications include pouchitis (inflammation of the ileal pouch), anastomotic leakage, small bowel obstruction, and pelvic sepsis. Regular follow-up care is essential to monitor for these and other potential issues.

Gastrointestinal endoscopy is a medical procedure that allows direct visualization of the inner lining of the digestive tract, which includes the esophagus, stomach, small intestine, large intestine (colon), and sometimes the upper part of the small intestine (duodenum). This procedure is performed using an endoscope, a long, thin, flexible tube with a light and camera at its tip. The endoscope is inserted through the mouth for upper endoscopy or through the rectum for lower endoscopy (colonoscopy), and the images captured by the camera are transmitted to a monitor for the physician to view.

Gastrointestinal endoscopy can help diagnose various conditions, such as inflammation, ulcers, tumors, polyps, or bleeding in the digestive tract. It can also be used for therapeutic purposes, such as removing polyps, taking tissue samples (biopsies), treating bleeding, and performing other interventions to manage certain digestive diseases.

There are different types of gastrointestinal endoscopy procedures, including:

1. Upper Endoscopy (Esophagogastroduodenoscopy or EGD): This procedure examines the esophagus, stomach, and duodenum.
2. Colonoscopy: This procedure examines the colon and rectum.
3. Sigmoidoscopy: A limited examination of the lower part of the colon (sigmoid colon) using a shorter endoscope.
4. Enteroscopy: An examination of the small intestine, which can be performed using various techniques, such as push enteroscopy, single-balloon enteroscopy, or double-balloon enteroscopy.
5. Capsule Endoscopy: A procedure that involves swallowing a small capsule containing a camera, which captures images of the digestive tract as it passes through.

Gastrointestinal endoscopy is generally considered safe when performed by experienced medical professionals. However, like any medical procedure, there are potential risks and complications, such as bleeding, infection, perforation, or adverse reactions to sedatives used during the procedure. Patients should discuss these risks with their healthcare provider before undergoing gastrointestinal endoscopy.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Indium is not a medical term, but it is a chemical element with the symbol In and atomic number 49. It is a soft, silvery-white, post-transition metal that is rarely found in its pure form in nature. It is primarily used in the production of electronics, such as flat panel displays, and in nuclear medicine as a radiation source for medical imaging.

In nuclear medicine, indium-111 is used in the labeling of white blood cells to diagnose and locate abscesses, inflammation, and infection. The indium-111 labeled white blood cells are injected into the patient's body, and then a gamma camera is used to track their movement and identify areas of infection or inflammation.

Therefore, while indium itself is not a medical term, it does have important medical applications in diagnostic imaging.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

Collagenous colitis is a type of chronic inflammatory bowel disease that affects the colon. It is characterized by the abnormal accumulation of collagen, a protein that provides structure to the body's tissues, beneath the lining of the colon. This can cause symptoms such as chronic watery diarrhea, abdominal pain, and bloating. The exact cause of collagenous colitis is not known, but it may be associated with autoimmune disorders or the use of certain medications. In some cases, the condition may resolve on its own, while in others, treatment with medications such as anti-inflammatory drugs or immunosuppressants may be necessary to manage symptoms and prevent complications.

Short Bowel Syndrome (SBS) is a malabsorption disorder that occurs when a significant portion of the small intestine has been removed or is functionally lost due to surgical resection, congenital abnormalities, or other diseases. The condition is characterized by an inability to absorb sufficient nutrients, water, and electrolytes from food, leading to diarrhea, malnutrition, dehydration, and weight loss.

The small intestine plays a crucial role in digestion and absorption of nutrients, and when more than 50% of its length is affected, the body's ability to absorb essential nutrients becomes compromised. The severity of SBS depends on the extent of the remaining small intestine, the presence or absence of the ileocecal valve (a sphincter that separates the small and large intestines), and the functionality of the residual intestinal segments.

Symptoms of Short Bowel Syndrome include:

1. Chronic diarrhea
2. Steatorrhea (fatty stools)
3. Dehydration
4. Weight loss
5. Fat-soluble vitamin deficiencies (A, D, E, and K)
6. Electrolyte imbalances
7. Malnutrition
8. Anemia
9. Bacterial overgrowth in the small intestine
10. Osteoporosis due to calcium and vitamin D deficiencies

Treatment for Short Bowel Syndrome typically involves a combination of nutritional support, medication, and sometimes surgical interventions. Nutritional management includes oral or enteral feeding with specially formulated elemental or semi-elemental diets, as well as parenteral nutrition (intravenous feeding) to provide essential nutrients that cannot be absorbed through the gastrointestinal tract. Medications such as antidiarrheals, H2 blockers, proton pump inhibitors, and antibiotics may also be used to manage symptoms and prevent complications. In some cases, intestinal transplantation might be considered for severe SBS patients who do not respond to other treatments.

The adrenal cortex hormones are a group of steroid hormones produced and released by the outer portion (cortex) of the adrenal glands, which are located on top of each kidney. These hormones play crucial roles in regulating various physiological processes, including:

1. Glucose metabolism: Cortisol helps control blood sugar levels by increasing glucose production in the liver and reducing its uptake in peripheral tissues.
2. Protein and fat metabolism: Cortisol promotes protein breakdown and fatty acid mobilization, providing essential building blocks for energy production during stressful situations.
3. Immune response regulation: Cortisol suppresses immune function to prevent overactivation and potential damage to the body during stress.
4. Cardiovascular function: Aldosterone regulates electrolyte balance and blood pressure by promoting sodium reabsorption and potassium excretion in the kidneys.
5. Sex hormone production: The adrenal cortex produces small amounts of sex hormones, such as androgens and estrogens, which contribute to sexual development and function.
6. Growth and development: Cortisol plays a role in normal growth and development by influencing the activity of growth-promoting hormones like insulin-like growth factor 1 (IGF-1).

The main adrenal cortex hormones include:

1. Glucocorticoids: Cortisol is the primary glucocorticoid, responsible for regulating metabolism and stress response.
2. Mineralocorticoids: Aldosterone is the primary mineralocorticoid, involved in electrolyte balance and blood pressure regulation.
3. Androgens: Dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEAS) are the most abundant adrenal androgens, contributing to sexual development and function.
4. Estrogens: Small amounts of estrogens are produced by the adrenal cortex, mainly in women.

Disorders related to impaired adrenal cortex hormone production or regulation can lead to various clinical manifestations, such as Addison's disease (adrenal insufficiency), Cushing's syndrome (hypercortisolism), and congenital adrenal hyperplasia (CAH).

"Helicobacter" is a genus of gram-negative, spiral-shaped bacteria that are commonly found in the stomach. The most well-known species is "Helicobacter pylori," which is known to cause various gastrointestinal diseases, such as gastritis, peptic ulcers, and gastric cancer. These bacteria are able to survive in the harsh acidic environment of the stomach by producing urease, an enzyme that neutralizes stomach acid. Infection with "Helicobacter pylori" is usually acquired in childhood and can persist for life if not treated.

Capsule endoscopy is a medical procedure that uses a small, pill-sized camera to capture images of the digestive tract. The capsule is swallowed and transmits images wirelessly as it moves through the gastrointestinal (GI) tract, allowing doctors to examine the lining of the small intestine, which can be difficult to reach with traditional endoscopes.

The procedure is commonly used to diagnose and monitor conditions such as Crohn's disease, celiac disease, obscure gastrointestinal bleeding, and tumors in the small intestine. The images captured by the capsule are transmitted to a recorder worn by the patient, and then reviewed and analyzed by a healthcare professional.

Capsule endoscopy is generally considered safe and non-invasive, with few risks or side effects. However, it may not be suitable for everyone, including patients with swallowing difficulties, pacemakers, or certain gastrointestinal obstructions. It's important to consult with a healthcare provider to determine if capsule endoscopy is the right diagnostic tool for a particular condition.

Diarrhea is a condition in which an individual experiences loose, watery stools frequently, often exceeding three times a day. It can be acute, lasting for several days, or chronic, persisting for weeks or even months. Diarrhea can result from various factors, including viral, bacterial, or parasitic infections, food intolerances, medications, and underlying medical conditions such as inflammatory bowel disease or irritable bowel syndrome. Dehydration is a potential complication of diarrhea, particularly in severe cases or in vulnerable populations like young children and the elderly.

Enteritis is a medical term that refers to inflammation of the small intestine. The small intestine is responsible for digesting and absorbing nutrients from food, so inflammation in this area can interfere with these processes and lead to symptoms such as diarrhea, abdominal pain, nausea, vomiting, and weight loss.

Enteritis can be caused by a variety of factors, including bacterial or viral infections, parasites, autoimmune disorders, medications, and exposure to toxins. In some cases, the cause of enteritis may be unknown. Treatment for enteritis depends on the underlying cause, but may include antibiotics, antiparasitic drugs, anti-inflammatory medications, or supportive care such as fluid replacement therapy.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

An ileostomy is a surgical procedure in which the end of the small intestine, called the ileum, is brought through an opening in the abdominal wall (stoma) to create a path for waste material to leave the body. This procedure is typically performed when there is damage or removal of the colon, rectum, or anal canal due to conditions such as inflammatory bowel disease (Crohn's disease or ulcerative colitis), cancer, or trauma.

After an ileostomy, waste material from the small intestine exits the body through the stoma and collects in a pouch worn outside the body. The patient needs to empty the pouch regularly, typically every few hours, as the output is liquid or semi-liquid. Ileostomies can be temporary or permanent, depending on the underlying condition and the planned course of treatment. Proper care and management of the stoma and pouch are essential for maintaining good health and quality of life after an ileostomy.

Monoclonal antibodies are a type of antibody that are identical because they are produced by a single clone of cells. They are laboratory-produced molecules that act like human antibodies in the immune system. They can be designed to attach to specific proteins found on the surface of cancer cells, making them useful for targeting and treating cancer. Monoclonal antibodies can also be used as a therapy for other diseases, such as autoimmune disorders and inflammatory conditions.

Monoclonal antibodies are produced by fusing a single type of immune cell, called a B cell, with a tumor cell to create a hybrid cell, or hybridoma. This hybrid cell is then able to replicate indefinitely, producing a large number of identical copies of the original antibody. These antibodies can be further modified and engineered to enhance their ability to bind to specific targets, increase their stability, and improve their effectiveness as therapeutic agents.

Monoclonal antibodies have several mechanisms of action in cancer therapy. They can directly kill cancer cells by binding to them and triggering an immune response. They can also block the signals that promote cancer growth and survival. Additionally, monoclonal antibodies can be used to deliver drugs or radiation directly to cancer cells, increasing the effectiveness of these treatments while minimizing their side effects on healthy tissues.

Monoclonal antibodies have become an important tool in modern medicine, with several approved for use in cancer therapy and other diseases. They are continuing to be studied and developed as a promising approach to treating a wide range of medical conditions.

Medical Definition of Microbiota:

The community of microorganisms, including bacteria, viruses, fungi, and other microscopic life forms, that inhabit a specific environment or body part. In the human body, microbiota can be found on the skin, in the mouth, gut, and other areas. The largest concentration of microbiota is located in the intestines, where it plays an essential role in digestion, immune function, and overall health.

The composition of the microbiota can vary depending on factors such as age, diet, lifestyle, genetics, and environmental exposures. Dysbiosis, or imbalance of the microbiota, has been linked to various health conditions, including gastrointestinal disorders, allergies, autoimmune diseases, and neurological disorders.

Therefore, maintaining a healthy and diverse microbiota is crucial for overall health and well-being. This can be achieved through a balanced diet, regular exercise, adequate sleep, stress management, and other lifestyle practices that support the growth and maintenance of beneficial microorganisms in the body.

Biological therapy, also known as biotherapy or immunotherapy, is a type of medical treatment that uses biological agents (such as substances derived from living organisms or laboratory-made versions of these substances) to identify and modify specific targets in the body to treat diseases, including cancer. These therapies can work by boosting the body's natural defenses to fight illness, interfering with the growth and spread of abnormal cells, or replacing absent or faulty proteins in the body. Examples of biological therapies include monoclonal antibodies, cytokines, and vaccines.

Aminosalicylic acid is an anti-inflammatory medication that is primarily used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. It works by reducing the production of chemicals in the body that cause inflammation in the intestines.

Aminosalicylic acid is available in various forms, including tablets, capsules, and enema formulations. The medication is typically taken at regular intervals, often several times a day, to maintain its effectiveness in reducing inflammation.

Common side effects of aminosalicylic acid include headache, nausea, vomiting, diarrhea, and abdominal pain. In some cases, the medication may cause more serious side effects such as kidney or liver problems, allergic reactions, or blood disorders. It is important to discuss any potential risks or side effects with a healthcare provider before starting treatment with aminosalicylic acid.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Colonic neoplasms refer to abnormal growths in the large intestine, also known as the colon. These growths can be benign (non-cancerous) or malignant (cancerous). The two most common types of colonic neoplasms are adenomas and carcinomas.

Adenomas are benign tumors that can develop into cancer over time if left untreated. They are often found during routine colonoscopies and can be removed during the procedure.

Carcinomas, on the other hand, are malignant tumors that invade surrounding tissues and can spread to other parts of the body. Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and colonic neoplasms are a significant risk factor for developing this type of cancer.

Regular screenings for colonic neoplasms are recommended for individuals over the age of 50 or those with a family history of colorectal cancer or other risk factors. Early detection and removal of colonic neoplasms can significantly reduce the risk of developing colorectal cancer.

The sigmoid colon is a part of the large intestine that forms an "S"-shaped curve before it joins the rectum. It gets its name from its unique shape, which resembles the Greek letter sigma (σ). The main function of the sigmoid colon is to store stool temporarily and assist in the absorption of water and electrolytes from digestive waste before it is eliminated from the body.

Functional colonic diseases are a group of disorders of the large intestine (colon) that do not have a structural or biochemical explanation. They are characterized by chronic and often intermittent symptoms, such as abdominal pain, bloating, and changes in bowel habits, but do not show any visible abnormalities or damage to the tissue of the colon during routine examination or testing.

The most common functional colonic diseases include:

1. Irritable Bowel Syndrome (IBS): A disorder characterized by recurrent abdominal pain, bloating, and changes in bowel habits, such as constipation or diarrhea.
2. Functional Constipation: A condition where a person experiences difficult or infrequent bowel movements, but there is no obvious structural or biochemical cause.
3. Functional Diarrhea: A disorder characterized by frequent loose stools, but without any underlying structural or biochemical abnormalities.
4. Abdominal Bloating: A condition where the belly feels full and tight, often accompanied by discomfort or pain, but without any visible distention.
5. Functional Abdominal Pain Syndrome: A disorder characterized by chronic or recurrent abdominal pain that is not associated with any structural or biochemical abnormalities.

The exact cause of functional colonic diseases is unknown, but they are believed to be related to a combination of factors, including genetics, environmental factors, altered gut motility, visceral hypersensitivity, and psychological factors such as stress and anxiety. Treatment typically involves lifestyle modifications, such as changes in diet and exercise, and medication to manage symptoms.

The cecum is the first part of the large intestine, located at the junction of the small and large intestines. It is a pouch-like structure that connects to the ileum (the last part of the small intestine) and the ascending colon (the first part of the large intestine). The cecum is where the appendix is attached. Its function is to absorb water and electrolytes, and it also serves as a site for the fermentation of certain types of dietary fiber by gut bacteria. However, the exact functions of the cecum are not fully understood.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Colorectal neoplasms refer to abnormal growths in the colon or rectum, which can be benign or malignant. These growths can arise from the inner lining (mucosa) of the colon or rectum and can take various forms such as polyps, adenomas, or carcinomas.

Benign neoplasms, such as hyperplastic polyps and inflammatory polyps, are not cancerous but may need to be removed to prevent the development of malignant tumors. Adenomas, on the other hand, are precancerous lesions that can develop into colorectal cancer if left untreated.

Colorectal cancer is a malignant neoplasm that arises from the uncontrolled growth and division of cells in the colon or rectum. It is one of the most common types of cancer worldwide and can spread to other parts of the body through the bloodstream or lymphatic system.

Regular screening for colorectal neoplasms is recommended for individuals over the age of 50, as early detection and removal of precancerous lesions can significantly reduce the risk of developing colorectal cancer.

Thioguanine is a medication that belongs to a class of drugs called antimetabolites. It is primarily used in the treatment of acute myeloid leukemia (AML) and other various types of cancer.

In medical terms, thioguanine is a purine analogue that gets metabolically converted into active thiopurine nucleotides, which then get incorporated into DNA and RNA, thereby interfering with the synthesis of genetic material in cancer cells. This interference leads to inhibition of cell division and growth, ultimately resulting in cell death (apoptosis) of the cancer cells.

It is important to note that thioguanine can also affect normal cells in the body, leading to various side effects. Therefore, it should be administered under the close supervision of a healthcare professional who can monitor its effectiveness and potential side effects.

Diverticulosis, colonic is a medical condition characterized by the presence of small sacs or pouches (diverticula) that form on the outer wall of the large intestine (colon). These sacs are usually found in the sigmoid colon, which is the part of the colon that is closest to the rectum.

Diverticulosis occurs when the inner layer of the colon's muscle pushes through weak spots in the outer layer of the colon wall, creating small pockets or sacs. The exact cause of diverticulosis is not known, but it may be associated with a low-fiber diet, aging, and increased pressure in the colon.

Most people with diverticulosis do not experience any symptoms, and the condition is often discovered during routine screening exams or when complications arise. However, some people may experience cramping, bloating, and changes in bowel habits.

Diverticulosis can lead to complications such as inflammation (diverticulitis), bleeding, and infection. It is important to seek medical attention if you experience symptoms such as severe abdominal pain, fever, or rectal bleeding, as these may be signs of a more serious condition.

Treatment for diverticulosis typically involves making dietary changes, increasing fiber intake, and taking medications to manage symptoms. In some cases, surgery may be necessary to remove affected portions of the colon.

Steroids, also known as corticosteroids, are a type of hormone that the adrenal gland produces in your body. They have many functions, such as controlling the balance of salt and water in your body and helping to reduce inflammation. Steroids can also be synthetically produced and used as medications to treat a variety of conditions, including allergies, asthma, skin conditions, and autoimmune disorders.

Steroid medications are available in various forms, such as oral pills, injections, creams, and inhalers. They work by mimicking the effects of natural hormones produced by your body, reducing inflammation and suppressing the immune system's response to prevent or reduce symptoms. However, long-term use of steroids can have significant side effects, including weight gain, high blood pressure, osteoporosis, and increased risk of infections.

It is important to note that anabolic steroids are a different class of drugs that are sometimes abused for their muscle-building properties. These steroids are synthetic versions of the male hormone testosterone and can have serious health consequences when taken in large doses or without medical supervision.

A mucous membrane is a type of moist, protective lining that covers various body surfaces inside the body, including the respiratory, gastrointestinal, and urogenital tracts, as well as the inner surface of the eyelids and the nasal cavity. These membranes are composed of epithelial cells that produce mucus, a slippery secretion that helps trap particles, microorganisms, and other foreign substances, preventing them from entering the body or causing damage to tissues. The mucous membrane functions as a barrier against infection and irritation while also facilitating the exchange of gases, nutrients, and waste products between the body and its environment.

Inflammation mediators are substances that are released by the body in response to injury or infection, which contribute to the inflammatory response. These mediators include various chemical factors such as cytokines, chemokines, prostaglandins, leukotrienes, and histamine, among others. They play a crucial role in regulating the inflammatory process by attracting immune cells to the site of injury or infection, increasing blood flow to the area, and promoting the repair and healing of damaged tissues. However, an overactive or chronic inflammatory response can also contribute to the development of various diseases and conditions, such as autoimmune disorders, cardiovascular disease, and cancer.

Helminthic therapy, also known as helminth therapy or worm therapy, is a medical treatment that involves the intentional introduction of specially selected species of parasitic worms, known as helminths, into the human body. The goal of this therapy is to treat or alleviate various immune-mediated inflammatory disorders and autoimmune diseases by modulating the host's immune response.

The most commonly used helminths in therapeutic settings are:

1. Necator americanus (hookworm): These are intestinal parasites that adults typically acquire through contact with contaminated soil. In a therapeutic setting, a small number of larvae are introduced into the patient's skin, which then migrate to the gastrointestinal tract and establish a low-level, chronic infection.
2. Trichuris suis (pig whipworm): This is another intestinal parasite that primarily infects pigs. In helminthic therapy, patients ingest ova (eggs) of T. suis, which hatch in the small intestine and mature into adults. However, these worms cannot complete their life cycle in humans and are expelled from the body within a few weeks.

The exact mechanisms through which helminthic therapy exerts its therapeutic effects are not fully understood, but it is believed that the presence of these non-pathogenic worms helps to restore immune homeostasis by modulating the host's immune response. This includes downregulation of pro-inflammatory cytokines and an increase in anti-inflammatory cytokines, which can help alleviate symptoms associated with various autoimmune and inflammatory conditions.

Helminthic therapy is still considered an experimental treatment and is not widely available or approved by regulatory agencies for the treatment of specific medical conditions. However, clinical trials and observational studies have suggested potential benefits in treating diseases such as inflammatory bowel disease (IBD), multiple sclerosis (MS), asthma, and allergies. It is essential to consult with a healthcare professional before considering helminthic therapy, as there are potential risks and side effects associated with the treatment.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

In the context of medicine and physiology, permeability refers to the ability of a tissue or membrane to allow the passage of fluids, solutes, or gases. It is often used to describe the property of the capillary walls, which control the exchange of substances between the blood and the surrounding tissues.

The permeability of a membrane can be influenced by various factors, including its molecular structure, charge, and the size of the molecules attempting to pass through it. A more permeable membrane allows for easier passage of substances, while a less permeable membrane restricts the movement of substances.

In some cases, changes in permeability can have significant consequences for health. For example, increased permeability of the blood-brain barrier (a specialized type of capillary that regulates the passage of substances into the brain) has been implicated in a number of neurological conditions, including multiple sclerosis, Alzheimer's disease, and traumatic brain injury.

Ankylosing spondylitis is a type of inflammatory arthritis that primarily affects the spine, although other joints can also be involved. It causes swelling in the spinal joints (vertebrae) that can lead to stiffness and pain. Over time, some of these joints may grow together, causing new bone formation and resulting in a rigid spine. This fusion of the spine is called ankylosis.

The condition typically begins in the sacroiliac joints, where the spine connects to the pelvis. From there, it can spread up the spine and potentially involve other areas of the body such as the eyes, heart, lungs, and gastrointestinal system.

Ankylosing spondylitis has a strong genetic link, with most people carrying the HLA-B27 gene. However, not everyone with this gene will develop the condition. It primarily affects males more often than females and tends to start in early adulthood.

Treatment usually involves a combination of medication, physical therapy, and exercise to help manage pain, maintain mobility, and prevent deformity. In severe cases, surgery may be considered.

Methyltransferases are a class of enzymes that catalyze the transfer of a methyl group (-CH3) from a donor molecule to an acceptor molecule, which is often a protein, DNA, or RNA. This transfer of a methyl group can modify the chemical and physical properties of the acceptor molecule, playing a crucial role in various cellular processes such as gene expression, signal transduction, and DNA repair.

In biochemistry, methyltransferases are classified based on the type of donor molecule they use for the transfer of the methyl group. The most common methyl donor is S-adenosylmethionine (SAM), a universal methyl group donor found in many organisms. Methyltransferases that utilize SAM as a cofactor are called SAM-dependent methyltransferases.

Abnormal regulation or function of methyltransferases has been implicated in several diseases, including cancer and neurological disorders. Therefore, understanding the structure, function, and regulation of these enzymes is essential for developing targeted therapies to treat these conditions.

Interleukin-23 (IL-23) is a pro-inflammatory cytokine, which is a type of signaling molecule used for communication between cells in the immune system. It is a heterodimeric protein composed of two subunits: p19 and p40. IL-23 plays a crucial role in the adaptive immune response by promoting the differentiation and activation of T-cells, particularly Th17 cells, which are involved in inflammatory responses.

IL-23 is produced primarily by activated dendritic cells and macrophages in response to various stimuli such as pathogens or tissue damage. Dysregulation of IL-23 has been implicated in several autoimmune diseases, including psoriasis, inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis. Therefore, therapeutic strategies targeting IL-23 are being explored as potential treatments for these conditions.

An intestinal fistula is an abnormal communication or connection between the intestines (or a portion of the intestine) and another organ or the skin surface. This connection forms a tract or passage, allowing the contents of the intestines, such as digestive enzymes, bacteria, and waste materials, to leak into other body areas or outside the body. Intestinal fistulas can develop due to various reasons, including inflammatory bowel diseases (like Crohn's disease), infections, complications from surgery, radiation therapy, or trauma. They can cause symptoms such as abdominal pain, diarrhea, skin irritation, and infection. Treatment of intestinal fistulas often involves a combination of medical management, nutritional support, and surgical intervention.

The small intestine is the portion of the gastrointestinal tract that extends from the pylorus of the stomach to the beginning of the large intestine (cecum). It plays a crucial role in the digestion and absorption of nutrients from food. The small intestine is divided into three parts: the duodenum, jejunum, and ileum.

1. Duodenum: This is the shortest and widest part of the small intestine, approximately 10 inches long. It receives chyme (partially digested food) from the stomach and begins the process of further digestion with the help of various enzymes and bile from the liver and pancreas.
2. Jejunum: The jejunum is the middle section, which measures about 8 feet in length. It has a large surface area due to the presence of circular folds (plicae circulares), finger-like projections called villi, and microvilli on the surface of the absorptive cells (enterocytes). These structures increase the intestinal surface area for efficient absorption of nutrients, electrolytes, and water.
3. Ileum: The ileum is the longest and final section of the small intestine, spanning about 12 feet. It continues the absorption process, mainly of vitamin B12, bile salts, and any remaining nutrients. At the end of the ileum, there is a valve called the ileocecal valve that prevents backflow of contents from the large intestine into the small intestine.

The primary function of the small intestine is to absorb the majority of nutrients, electrolytes, and water from ingested food. The mucosal lining of the small intestine contains numerous goblet cells that secrete mucus, which protects the epithelial surface and facilitates the movement of chyme through peristalsis. Additionally, the small intestine hosts a diverse community of microbiota, which contributes to various physiological functions, including digestion, immunity, and protection against pathogens.

Immunologic factors refer to the elements of the immune system that contribute to the body's defense against foreign substances, infectious agents, and cancerous cells. These factors include various types of white blood cells (such as lymphocytes, neutrophils, monocytes, and eosinophils), antibodies, complement proteins, cytokines, and other molecules involved in the immune response.

Immunologic factors can be categorized into two main types: innate immunity and adaptive immunity. Innate immunity is the non-specific defense mechanism that provides immediate protection against pathogens through physical barriers (e.g., skin, mucous membranes), chemical barriers (e.g., stomach acid, enzymes), and inflammatory responses. Adaptive immunity, on the other hand, is a specific defense mechanism that develops over time as the immune system learns to recognize and respond to particular pathogens or antigens.

Abnormalities in immunologic factors can lead to various medical conditions, such as autoimmune disorders, immunodeficiency diseases, and allergies. Therefore, understanding immunologic factors is crucial for diagnosing and treating these conditions.

"Administration, Rectal" is a medical term that refers to the process of administering medication or other substances through the rectum. This route of administration is also known as "rectal suppository" or "suppository administration."

In this method, a solid dosage form called a suppository is inserted into the rectum using fingers or a special applicator. Once inside, the suppository melts or dissolves due to the body's temperature and releases the active drug or substance, which then gets absorbed into the bloodstream through the walls of the rectum.

Rectal administration is an alternative route of administration for people who have difficulty swallowing pills or liquids, or when rapid absorption of the medication is necessary. It can also be used to administer medications that are not well absorbed through other routes, such as the gastrointestinal tract. However, it may take longer for the medication to reach the bloodstream compared to intravenous (IV) administration.

Common examples of rectally administered medications include laxatives, antidiarrheal agents, analgesics, and some forms of hormonal therapy. It is important to follow the instructions provided by a healthcare professional when administering medication rectally, as improper administration can reduce the effectiveness of the medication or cause irritation or discomfort.

Rectal diseases refer to conditions that affect the structure or function of the rectum, which is the lower end of the large intestine, just above the anus. The rectum serves as a storage area for stool before it is eliminated from the body. Some common rectal diseases include:

1. Hemorrhoids: Swollen veins in the rectum or anus that can cause pain, itching, bleeding, and discomfort.
2. Rectal cancer: Abnormal growth of cells in the rectum that can invade and destroy nearby tissue and spread to other parts of the body.
3. Anal fissures: Small tears in the lining of the anus that can cause pain, bleeding, and itching.
4. Rectal prolapse: A condition where the rectum slips outside the anus, causing discomfort, fecal incontinence, and other symptoms.
5. Inflammatory bowel disease (IBD): A group of chronic inflammatory conditions that affect the digestive tract, including the rectum, such as Crohn's disease and ulcerative colitis.
6. Rectal abscess: A collection of pus in the rectum caused by an infection, which can cause pain, swelling, and fever.
7. Fistula-in-ano: An abnormal connection between the rectum and the skin around the anus, which can cause drainage of pus or stool.
8. Rectal foreign bodies: Objects that are accidentally or intentionally inserted into the rectum and can cause injury, infection, or obstruction.

These are just a few examples of rectal diseases, and there are many other conditions that can affect the rectum. If you experience any symptoms related to the rectum, it is important to seek medical attention from a healthcare professional for proper diagnosis and treatment.

Prednisolone is a synthetic glucocorticoid drug, which is a class of steroid hormones. It is commonly used in the treatment of various inflammatory and autoimmune conditions due to its potent anti-inflammatory and immunosuppressive effects. Prednisolone works by binding to specific receptors in cells, leading to changes in gene expression that reduce the production of substances involved in inflammation, such as cytokines and prostaglandins.

Prednisolone is available in various forms, including tablets, syrups, and injectable solutions. It can be used to treat a wide range of medical conditions, including asthma, rheumatoid arthritis, inflammatory bowel disease, allergies, skin conditions, and certain types of cancer.

Like other steroid medications, prednisolone can have significant side effects if used in high doses or for long periods of time. These may include weight gain, mood changes, increased risk of infections, osteoporosis, diabetes, and adrenal suppression. As a result, the use of prednisolone should be closely monitored by a healthcare professional to ensure that its benefits outweigh its risks.

A diverticulum of the colon is a small sac or pouch that forms in the wall of the large intestine (colon). These sacs usually develop in areas where the blood vessels pass through the muscle layer of the colon, creating a weak spot that eventually bulges outward. Diverticula can occur anywhere along the length of the colon, but they are most commonly found in the lower part of the colon, also known as the sigmoid colon.

Diverticula themselves are not harmful and often do not cause any symptoms. However, when these sacs become inflamed or infected, it can lead to a condition called diverticulitis, which can cause pain, fever, nausea, vomiting, constipation, or diarrhea. Diverticulitis is usually treated with antibiotics and a liquid diet, but in severe cases, surgery may be required.

Risk factors for developing colonic diverticula include aging, obesity, smoking, low fiber intake, and lack of physical activity. Regular screening is recommended for individuals over the age of 50 to detect and prevent complications associated with diverticular disease.

Lymphocytic colitis is a type of microscopic colitis, which is a chronic inflammatory condition that affects the large intestine (colon). In lymphocytic colitis, there is an increased number of lymphocytes (a type of white blood cell) in the lining of the colon. This inflammation can cause symptoms such as chronic watery diarrhea, abdominal cramps, and urgency. The exact cause of lymphocytic colitis is not known, but it is thought to be related to an immune response to an environmental trigger in genetically susceptible individuals. It is more common in women than men and typically affects people over the age of 40. Treatment may include medications such as anti-diarrheal agents, corticosteroids, or immunosuppressive drugs. In some cases, dietary modifications or elimination of certain foods from the diet may also be helpful in managing symptoms.

The digestive system, also known as the gastrointestinal (GI) tract, is a series of organs that process food and liquids into nutrients and waste. Digestive system diseases refer to any conditions that affect the normal functioning of this system, leading to impaired digestion, absorption, or elimination of food and fluids.

Some common examples of digestive system diseases include:

1. Gastroesophageal Reflux Disease (GERD): A condition where stomach acid flows back into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.
2. Peptic Ulcer Disease: Sores or ulcers that develop in the lining of the stomach or duodenum, often caused by bacterial infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
3. Inflammatory Bowel Disease (IBD): A group of chronic inflammatory conditions that affect the intestines, including Crohn's disease and ulcerative colitis.
4. Irritable Bowel Syndrome (IBS): A functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits.
5. Celiac Disease: An autoimmune disorder where the ingestion of gluten leads to damage in the small intestine, impairing nutrient absorption.
6. Diverticular Disease: A condition that affects the colon, characterized by the formation of small pouches or sacs (diverticula) that can become inflamed or infected.
7. Constipation: A common digestive system issue where bowel movements occur less frequently than usual or are difficult to pass.
8. Diarrhea: Loose, watery stools that occur more frequently than normal, often accompanied by cramps and bloating.
9. Gallstones: Small, hard deposits that form in the gallbladder, causing pain, inflammation, and potential blockages of the bile ducts.
10. Hepatitis: Inflammation of the liver, often caused by viral infections or toxins, leading to symptoms such as jaundice, fatigue, and abdominal pain.

These are just a few examples of digestive system disorders that can affect overall health and quality of life. If you experience any persistent or severe digestive symptoms, it is important to seek medical attention from a healthcare professional.

Epithelial cells are types of cells that cover the outer surfaces of the body, line the inner surfaces of organs and glands, and form the lining of blood vessels and body cavities. They provide a protective barrier against the external environment, regulate the movement of materials between the internal and external environments, and are involved in the sense of touch, temperature, and pain. Epithelial cells can be squamous (flat and thin), cuboidal (square-shaped and of equal height), or columnar (tall and narrow) in shape and are classified based on their location and function.

The "age of onset" is a medical term that refers to the age at which an individual first develops or displays symptoms of a particular disease, disorder, or condition. It can be used to describe various medical conditions, including both physical and mental health disorders. The age of onset can have implications for prognosis, treatment approaches, and potential causes of the condition. In some cases, early onset may indicate a more severe or progressive course of the disease, while late-onset symptoms might be associated with different underlying factors or etiologies. It is essential to provide accurate and precise information regarding the age of onset when discussing a patient's medical history and treatment plan.

Microscopic colitis is a type of inflammatory bowel disease that is characterized by chronic inflammation of the colon (large intestine) that can only be seen under a microscope. It is called "microscopic" because the inflammation is not visible to the naked eye during endoscopic examination of the colon.

There are two main types of microscopic colitis: collagenous colitis and lymphocytic colitis. Both types are more common in older adults, particularly women, and can cause chronic watery diarrhea that may be accompanied by abdominal cramps, bloating, and nausea.

In collagenous colitis, there is thickening of the collagen band (a layer of tissue) beneath the lining of the colon. In lymphocytic colitis, there is an increase in the number of lymphocytes (a type of white blood cell) in the lining of the colon.

The exact cause of microscopic colitis is not known, but it is thought to be related to a combination of genetic, environmental, and immune factors. Treatment typically involves medications to reduce inflammation and manage symptoms, such as anti-diarrheal agents, corticosteroids, and immunosuppressive drugs. In some cases, dietary modifications or elimination of certain foods may also help alleviate symptoms.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Leukocytes, also known as white blood cells (WBCs), are a crucial component of the human immune system. They are responsible for protecting the body against infections and foreign substances. Leukocytes are produced in the bone marrow and circulate throughout the body in the bloodstream and lymphatic system.

There are several types of leukocytes, including:

1. Neutrophils - These are the most abundant type of leukocyte and are primarily responsible for fighting bacterial infections. They contain enzymes that can destroy bacteria.
2. Lymphocytes - These are responsible for producing antibodies and destroying virus-infected cells, as well as cancer cells. There are two main types of lymphocytes: B-lymphocytes and T-lymphocytes.
3. Monocytes - These are the largest type of leukocyte and help to break down and remove dead or damaged tissues, as well as microorganisms.
4. Eosinophils - These play a role in fighting parasitic infections and are also involved in allergic reactions and inflammation.
5. Basophils - These release histamine and other chemicals that cause inflammation in response to allergens or irritants.

An abnormal increase or decrease in the number of leukocytes can indicate an underlying medical condition, such as an infection, inflammation, or a blood disorder.

Blood sedimentation, also known as erythrocyte sedimentation rate (ESR), is a medical test that measures the rate at which red blood cells settle at the bottom of a tube of unclotted blood over a specific period of time. The test is used to detect and monitor inflammation in the body.

During an acute inflammatory response, certain proteins in the blood, such as fibrinogen, increase in concentration. These proteins cause red blood cells to stick together and form rouleaux (stacks of disc-shaped cells). As a result, the red blood cells settle more quickly, leading to a higher ESR.

The ESR test is a non-specific test, meaning that it does not identify the specific cause of inflammation. However, it can be used as an indicator of underlying conditions such as infections, autoimmune diseases, and cancer. The test is also used to monitor the effectiveness of treatment for these conditions.

The ESR test is usually performed by drawing a sample of blood into a special tube and allowing it to sit undisturbed for one hour. The distance that the red blood cells have settled is then measured and recorded as the ESR. Normal values for ESR vary depending on age and gender, with higher values indicating greater inflammation.

Innate immunity, also known as non-specific immunity or natural immunity, is the inherent defense mechanism that provides immediate protection against potentially harmful pathogens (like bacteria, viruses, fungi, and parasites) without the need for prior exposure. This type of immunity is present from birth and does not adapt to specific threats over time.

Innate immune responses involve various mechanisms such as:

1. Physical barriers: Skin and mucous membranes prevent pathogens from entering the body.
2. Chemical barriers: Enzymes, stomach acid, and lysozyme in tears, saliva, and sweat help to destroy or inhibit the growth of microorganisms.
3. Cellular responses: Phagocytic cells (neutrophils, monocytes, macrophages) recognize and engulf foreign particles and pathogens, while natural killer (NK) cells target and eliminate virus-infected or cancerous cells.
4. Inflammatory response: When an infection occurs, the innate immune system triggers inflammation to increase blood flow, recruit immune cells, and remove damaged tissue.
5. Complement system: A group of proteins that work together to recognize and destroy pathogens directly or enhance phagocytosis by coating them with complement components (opsonization).

Innate immunity plays a crucial role in initiating the adaptive immune response, which is specific to particular pathogens and provides long-term protection through memory cells. Both innate and adaptive immunity work together to maintain overall immune homeostasis and protect the body from infections and diseases.

Colonic pouches, also known as pouch colon or reservoir, refer to an artificial structure created during a surgical procedure called restorative proctocolectomy. This is often performed in patients with certain types of inflammatory bowel disease like ulcerative colitis or familial adenomatous polyposis.

During the surgery, the entire colon and rectum are removed. A pouch is then created using the patient's own small intestine, which is folded back on itself and sewn together to form a reservoir. This pouch is connected to the anus, allowing the patient to have relatively normal bowel movements.

The most common type of colonic pouch is the J-pouch, so named because of its J-shaped design. Other types include the S-pouch and the W-pouch. The choice of pouch depends on various factors, including the patient's anatomy and the surgeon's preference.

The purpose of creating a colonic pouch is to restore intestinal continuity and function after removing the diseased colon and rectum, thereby improving the patient's quality of life. However, it's important to note that living with a colonic pouch also requires significant lifestyle adjustments and ongoing medical management.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Glucocorticoids are a class of steroid hormones that are naturally produced in the adrenal gland, or can be synthetically manufactured. They play an essential role in the metabolism of carbohydrates, proteins, and fats, and have significant anti-inflammatory effects. Glucocorticoids suppress immune responses and inflammation by inhibiting the release of inflammatory mediators from various cells, such as mast cells, eosinophils, and lymphocytes. They are frequently used in medical treatment for a wide range of conditions, including allergies, asthma, rheumatoid arthritis, dermatological disorders, and certain cancers. Prolonged use or high doses of glucocorticoids can lead to several side effects, such as weight gain, mood changes, osteoporosis, and increased susceptibility to infections.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide (A, T, C, or G) in the DNA sequence is altered. This alteration must occur in at least 1% of the population to be considered a SNP. These variations can help explain why some people are more susceptible to certain diseases than others and can also influence how an individual responds to certain medications. SNPs can serve as biological markers, helping scientists locate genes that are associated with disease. They can also provide information about an individual's ancestry and ethnic background.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

The digestive system is a series of organs that work together to convert food into nutrients and energy. Digestive system surgical procedures involve operations on any part of the digestive system, including the esophagus, stomach, small intestine, large intestine, liver, pancreas, and gallbladder. These procedures can be performed for a variety of reasons, such as to treat diseases, repair damage, or remove cancerous growths.

Some common digestive system surgical procedures include:

1. Gastric bypass surgery: A procedure in which the stomach is divided into two parts and the smaller part is connected directly to the small intestine, bypassing a portion of the stomach and upper small intestine. This procedure is used to treat severe obesity.
2. Colonoscopy: A procedure in which a flexible tube with a camera on the end is inserted into the rectum and colon to examine the lining for polyps, cancer, or other abnormalities.
3. Colectomy: A procedure in which all or part of the colon is removed, often due to cancer, inflammatory bowel disease, or diverticulitis.
4. Gastrostomy: A procedure in which a hole is made through the abdominal wall and into the stomach to create an opening for feeding. This is often done for patients who have difficulty swallowing.
5. Esophagectomy: A procedure in which all or part of the esophagus is removed, often due to cancer. The remaining esophagus is then reconnected to the stomach or small intestine.
6. Liver resection: A procedure in which a portion of the liver is removed, often due to cancer or other diseases.
7. Pancreatectomy: A procedure in which all or part of the pancreas is removed, often due to cancer or chronic pancreatitis.
8. Cholecystectomy: A procedure in which the gallbladder is removed, often due to gallstones or inflammation.

These are just a few examples of digestive system surgical procedures. There are many other types of operations that can be performed on the digestive system depending on the specific needs and condition of each patient.

Enterocytes are the absorptive cells that line the villi of the small intestine. They are a type of epithelial cell and play a crucial role in the absorption of nutrients from food into the bloodstream. Enterocytes have finger-like projections called microvilli on their apical surface, which increases their surface area and enhances their ability to absorb nutrients. They also contain enzymes that help digest and break down carbohydrates, proteins, and fats into smaller molecules that can be absorbed. Additionally, enterocytes play a role in the absorption of ions, water, and vitamins.

T-lymphocytes, also known as T-cells, are a type of white blood cell that plays a key role in the adaptive immune system's response to infection. They are produced in the bone marrow and mature in the thymus gland. There are several different types of T-cells, including CD4+ helper T-cells, CD8+ cytotoxic T-cells, and regulatory T-cells (Tregs).

CD4+ helper T-cells assist in activating other immune cells, such as B-lymphocytes and macrophages. They also produce cytokines, which are signaling molecules that help coordinate the immune response. CD8+ cytotoxic T-cells directly kill infected cells by releasing toxic substances. Regulatory T-cells help maintain immune tolerance and prevent autoimmune diseases by suppressing the activity of other immune cells.

T-lymphocytes are important in the immune response to viral infections, cancer, and other diseases. Dysfunction or depletion of T-cells can lead to immunodeficiency and increased susceptibility to infections. On the other hand, an overactive T-cell response can contribute to autoimmune diseases and chronic inflammation.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Genetic polymorphism refers to the occurrence of multiple forms (called alleles) of a particular gene within a population. These variations in the DNA sequence do not generally affect the function or survival of the organism, but they can contribute to differences in traits among individuals. Genetic polymorphisms can be caused by single nucleotide changes (SNPs), insertions or deletions of DNA segments, or other types of genetic rearrangements. They are important for understanding genetic diversity and evolution, as well as for identifying genetic factors that may contribute to disease susceptibility in humans.

Intestinal neoplasms refer to abnormal growths in the tissues of the intestines, which can be benign or malignant. These growths are called neoplasms and they result from uncontrolled cell division. In the case of intestinal neoplasms, these growths occur in the small intestine, large intestine (colon), rectum, or appendix.

Benign intestinal neoplasms are not cancerous and often do not invade surrounding tissues or spread to other parts of the body. However, they can still cause problems if they grow large enough to obstruct the intestines or cause bleeding. Common types of benign intestinal neoplasms include polyps, leiomyomas, and lipomas.

Malignant intestinal neoplasms, on the other hand, are cancerous and can invade surrounding tissues and spread to other parts of the body. The most common type of malignant intestinal neoplasm is adenocarcinoma, which arises from the glandular cells lining the inside of the intestines. Other types of malignant intestinal neoplasms include lymphomas, sarcomas, and carcinoid tumors.

Symptoms of intestinal neoplasms can vary depending on their size, location, and type. Common symptoms include abdominal pain, bloating, changes in bowel habits, rectal bleeding, weight loss, and fatigue. If you experience any of these symptoms, it is important to seek medical attention promptly.

Regulatory T-lymphocytes (Tregs), also known as suppressor T cells, are a subpopulation of T-cells that play a critical role in maintaining immune tolerance and preventing autoimmune diseases. They function to suppress the activation and proliferation of other immune cells, thereby regulating the immune response and preventing it from attacking the body's own tissues.

Tregs constitutively express the surface markers CD4 and CD25, as well as the transcription factor Foxp3, which is essential for their development and function. They can be further divided into subsets based on their expression of other markers, such as CD127 and CD45RA.

Tregs are critical for maintaining self-tolerance by suppressing the activation of self-reactive T cells that have escaped negative selection in the thymus. They also play a role in regulating immune responses to foreign antigens, such as those encountered during infection or cancer, and can contribute to the immunosuppressive microenvironment found in tumors.

Dysregulation of Tregs has been implicated in various autoimmune diseases, including type 1 diabetes, rheumatoid arthritis, and multiple sclerosis, as well as in cancer and infectious diseases. Therefore, understanding the mechanisms that regulate Treg function is an important area of research with potential therapeutic implications.

An enterostomy is a surgical procedure that creates an opening from the intestine to the abdominal wall, which allows for the elimination of waste from the body. This opening is called a stoma and can be temporary or permanent, depending on the individual's medical condition. There are several types of enterostomies, including colostomy, ileostomy, and jejunostomy, which differ based on the specific location in the intestine where the stoma is created.

The purpose of an enterostomy may vary, but it is often performed to divert the flow of waste away from a diseased or damaged section of the intestine, allowing it to heal. Common reasons for an enterostomy include inflammatory bowel disease, cancer, trauma, and birth defects.

After the surgery, patients will need to wear a pouching system over the stoma to collect waste. They will also require specialized care and education on how to manage their stoma and maintain their overall health. With proper care and support, individuals with an enterostomy can lead active and fulfilling lives.

NOD1 (Nucleotide-binding Oligomerization Domain-containing protein 1) signaling adaptor protein, also known as CARD4 (Caspase Recruitment Domain-containing protein 4), is an intracellular protein that plays a crucial role in the innate immune response. It belongs to the family of NOD-like receptors (NLRs) and functions as a pattern recognition receptor (PRR) that recognizes specific molecular patterns, known as pathogen-associated molecular patterns (PAMPs), derived from various microbial pathogens.

NOD1 signaling adaptor protein contains two functional domains: a C-terminal leucine-rich repeat (LRR) domain, which is responsible for recognizing PAMPs, and an N-terminal caspase recruitment domain (CARD). Upon recognition of PAMPs, NOD1 undergoes conformational changes leading to self-oligomerization and the formation of a signaling platform. This platform recruits downstream effector proteins, such as RIPK2 (Receptor-Interacting Protein Kinase 2), via homotypic CARD-CARD interactions, ultimately activating NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) and MAPKs (Mitogen-Activated Protein Kinases) signaling pathways. These signaling cascades result in the production of proinflammatory cytokines, chemokines, and antimicrobial peptides to combat invading microorganisms.

In summary, NOD1 signaling adaptor protein is an essential component of the innate immune system that detects specific PAMPs from microbial pathogens and triggers downstream signaling events leading to inflammatory responses and host defense mechanisms.

I'm sorry for any confusion, but "Sizofiran" is not a recognized term in medical terminology. It's possible that you may be referring to "sodium hyaluronate," which is also known as hyaluronan or hyaluronic acid. This is a substance naturally found in the body, particularly in the eyes, joints, and skin where it helps with lubrication and cushioning.

In a medical context, sodium hyaluronate is often used as a treatment for osteoarthritis, where it is injected into the affected joint to help reduce pain and improve mobility. It's also used in various cosmetic and skincare products due to its moisture-retaining properties.

If you meant something else by "Sizofiran," could you please provide more context or clarify? I'm here to help!

T helper 17 (Th17) cells are a subset of CD4+ T cells, which are a type of white blood cell that plays a crucial role in the immune response. Th17 cells are characterized by their production of certain cytokines, including interleukin-17 (IL-17), IL-21, and IL-22. They are involved in the inflammatory response and play a key role in protecting the body against extracellular bacteria and fungi. However, an overactive Th17 response has been implicated in several autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and psoriasis. Therefore, understanding the regulation of Th17 cells is important for developing new therapies to treat these conditions.

Mucoproteins are a type of complex protein that contain covalently bound carbohydrate chains, also known as glycoproteins. They are found in various biological tissues and fluids, including mucous secretions, blood, and connective tissue. In mucous secretions, mucoproteins help to form a protective layer over epithelial surfaces, such as the lining of the respiratory and gastrointestinal tracts, by providing lubrication, hydration, and protection against pathogens and environmental insults.

The carbohydrate chains in mucoproteins are composed of various sugars, including hexoses, hexosamines, and sialic acids, which can vary in length and composition depending on the specific protein. These carbohydrate chains play important roles in the structure and function of mucoproteins, such as modulating their solubility, stability, and interactions with other molecules.

Mucoproteins have been implicated in various physiological and pathological processes, including inflammation, immune response, and tissue repair. Abnormalities in the structure or function of mucoproteins have been associated with several diseases, such as mucopolysaccharidoses, a group of inherited metabolic disorders caused by deficiencies in enzymes that break down glycosaminoglycans (GAGs), which are long, unbranched carbohydrate chains found in mucoproteins.

CD4-positive T-lymphocytes, also known as CD4+ T cells or helper T cells, are a type of white blood cell that plays a crucial role in the immune response. They express the CD4 receptor on their surface and help coordinate the immune system's response to infectious agents such as viruses and bacteria.

CD4+ T cells recognize and bind to specific antigens presented by antigen-presenting cells, such as dendritic cells or macrophages. Once activated, they can differentiate into various subsets of effector cells, including Th1, Th2, Th17, and Treg cells, each with distinct functions in the immune response.

CD4+ T cells are particularly important in the immune response to HIV (human immunodeficiency virus), which targets and destroys these cells, leading to a weakened immune system and increased susceptibility to opportunistic infections. The number of CD4+ T cells is often used as a marker of disease progression in HIV infection, with lower counts indicating more advanced disease.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Diverticulitis, Colonic is a medical condition characterized by the inflammation or infection of one or more diverticula in the colon. Diverticula are small, bulging pouches that form in the wall of the colon, usually in older adults. They are caused by increased pressure on weakened areas of the colon wall, resulting in the formation of these sac-like protrusions.

When diverticula become inflamed or infected, it leads to the condition known as diverticulitis. Symptoms of colonic diverticulitis may include abdominal pain, fever, nausea, vomiting, constipation or diarrhea, and a decreased appetite. In severe cases, complications such as perforation, abscess formation, or peritonitis (inflammation of the lining of the abdominal cavity) may occur, requiring hospitalization and surgical intervention.

The exact cause of diverticulitis is not fully understood, but it is believed to be associated with a low-fiber diet, obesity, smoking, and lack of exercise. Treatment typically involves antibiotics to clear the infection, a liquid diet to allow the colon to rest, and over-the-counter or prescription pain medications to manage discomfort. In severe cases or in patients who experience recurrent episodes of diverticulitis, surgery may be necessary to remove the affected portion of the colon.

The descending colon is a part of the large intestine in the human digestive system. It is called "descending" because it is located inferiorly and posteriorly to the transverse colon, and its direction goes downward as it continues toward the rectum. The descending colon receives digested food material from the transverse colon via the splenic flexure, also known as the left colic flexure.

The primary function of the descending colon is to absorb water, electrolytes, and any remaining nutrients from the undigested food materials that have passed through the small intestine. The descending colon also stores this waste material temporarily before it moves into the rectum for eventual elimination from the body.

The descending colon's wall contains a layer of smooth muscle, which helps propel the waste material along the gastrointestinal tract via peristalsis. Additionally, the inner mucosal lining of the descending colon contains numerous goblet cells that produce and secrete mucus to lubricate the passage of stool and protect the intestinal wall from irritation or damage caused by waste materials.

In summary, the medical definition of 'Colon, Descending' refers to a section of the large intestine responsible for absorbing water and electrolytes while storing and eliminating waste materials through peristaltic movements and mucus secretion.

Sigmoidoscopy is a medical procedure that involves the insertion of a sigmoidoscope, a flexible tube with a light and camera at the end, into the rectum and lower colon (sigmoid colon) to examine these areas for any abnormalities such as inflammation, ulcers, polyps, or cancer. The procedure typically allows for the detection of issues in the sigmoid colon and rectum, and can help diagnose conditions such as inflammatory bowel disease, diverticulosis, or colorectal cancer.

There are two types of sigmoidoscopy: flexible sigmoidoscopy and rigid sigmoidoscopy. Flexible sigmoidoscopy is more commonly performed because it provides a better view of the lower colon and is less uncomfortable for the patient. Rigid sigmoidoscopy, on the other hand, uses a solid, inflexible tube and is typically used in specific situations such as the removal of foreign objects or certain types of polyps.

During the procedure, patients are usually positioned on their left side with their knees drawn up to their chest. The sigmoidoscope is gently inserted into the rectum and advanced through the lower colon while the doctor examines the lining for any abnormalities. Air may be introduced through the scope to help expand the colon and provide a better view. If polyps or other abnormal tissues are found, they can often be removed during the procedure for further examination and testing.

Sigmoidoscopy is generally considered a safe and well-tolerated procedure. Some patients may experience mild discomfort, bloating, or cramping during or after the exam, but these symptoms typically resolve on their own within a few hours.

Pyoderma is a term used in medicine to describe a bacterial skin infection. It's derived from two Greek words: "pyon" meaning pus and "derma" meaning skin.

The infection can result in inflammation, often characterized by redness, swelling, warmth, and pain. Pus-filled blisters or boils may also form, which can rupture and crust over as the infection progresses.

Pyoderma can occur in people of all ages but is particularly common in children. The causative bacteria are often Staphylococcus aureus or Streptococcus pyogenes. The condition can be superficial, affecting only the top layer of the skin (epidermis), or it can be deeper, involving the dermis and/or subcutaneous tissue.

Treatment typically involves antibiotics, either topical or oral, depending on the severity and extent of the infection. In some cases, drainage of pus-filled abscesses may be necessary. Preventive measures such as good hygiene and keeping skin clean and dry can help reduce the risk of pyoderma.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

HLA-B27 antigen is a type of human leukocyte antigen (HLA) found on the surface of white blood cells. HLAs are proteins that help the body's immune system distinguish its own cells from foreign substances such as viruses and bacteria.

HLA-B27 is a specific type of HLA-B antigen, which is part of the major histocompatibility complex (MHC) class I molecules. The presence of HLA-B27 antigen can be inherited from parents to their offspring.

While most people with the HLA-B27 antigen do not develop any health problems, this antigen is associated with an increased risk of developing certain inflammatory diseases, particularly spondyloarthritis, a group of disorders that affect the joints and spine. Examples of these conditions include ankylosing spondylitis, reactive arthritis, psoriatic arthritis, and enteropathic arthritis associated with inflammatory bowel disease. However, not everyone with HLA-B27 will develop these diseases, and many people without the antigen can still develop spondyloarthritis.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

Quality of Life (QOL) is a broad, multidimensional concept that usually includes an individual's physical health, psychological state, level of independence, social relationships, personal beliefs, and their relationship to salient features of their environment. It reflects the impact of disease and treatment on a patient's overall well-being and ability to function in daily life.

The World Health Organization (WHO) defines QOL as "an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns." It is a subjective concept, meaning it can vary greatly from person to person.

In healthcare, QOL is often used as an outcome measure in clinical trials and other research studies to assess the impact of interventions or treatments on overall patient well-being.

Autoimmune diseases are a group of disorders in which the immune system, which normally protects the body from foreign invaders like bacteria and viruses, mistakenly attacks the body's own cells and tissues. This results in inflammation and damage to various organs and tissues in the body.

In autoimmune diseases, the body produces autoantibodies that target its own proteins or cell receptors, leading to their destruction or malfunction. The exact cause of autoimmune diseases is not fully understood, but it is believed that a combination of genetic and environmental factors contribute to their development.

There are over 80 different types of autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, Hashimoto's thyroiditis, Graves' disease, psoriasis, and inflammatory bowel disease. Symptoms can vary widely depending on the specific autoimmune disease and the organs or tissues affected. Treatment typically involves managing symptoms and suppressing the immune system to prevent further damage.

Access information on inflammatory bowel disorder and inflammatory bowel disease treatment. ... and guidelines on chronic inflammatory bowel disease symptoms, or IBD symptoms. ... Inflammatory Bowel Disease : Review in-depth clinical information, latest medical news, ...
Learn basic information about inflammatory bowel disease (IBD), symptoms, causes, diagnosis and treatment. ... Inflammatory bowel disease (IBD) is a term for two conditions (Crohns disease and ulcerative colitis) that are characterized ... Crohs Disease and Ulcerative Colitis. Crohns Disease. Ulcerative Colitis. Affected Location. Can affect any part of the GI ... Content source: National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention ...
Inflammatory bowel disease-22 World Inflammatory Bowel Disease Day GBD 2015 Disease and Injury Incidence and Prevalence ... The chief types of inflammatory bowel disease are Crohns disease and ulcerative colitis (UC). Inflammatory bowel diseases fall ... Cario E (September 2010). "Toll-like receptors in inflammatory bowel diseases: a decade later". Inflammatory Bowel Diseases. 16 ... Implications in Inflammatory Bowel Disease". Inflammatory Bowel Diseases. 21 (10): 2403-2417. doi:10.1097/MIB.0000000000000506 ...
... immunologic sensitivity should be excluded as far as possible before a diagnosis of non-specific inflammatory bowel disease is ... Classification of inflammatory bowel disease Scand J Gastroenterol Suppl. 1989:170:2-6; discussion 16-9. doi: 10.3109/ ... immunologic sensitivity should be excluded as far as possible before a diagnosis of non-specific inflammatory bowel disease is ...
Bowel Disease Crohns Disease reference library for patients interested in finding info on Inflammatory Bowel Disease Crohns ... Inflammatory Bowel Disease: Symptoms and Treatment Inflammatory bowel disease (IBD) can come with painful flare-ups. Find out ... Both Crohns disease and ulcerative colitis are inflammatory bowel diseases. They share many symptoms, so its easy to confuse ... Inflammatory Bowel Disease Crohns Disease Medical Reference. Latest Article IBD in People of Color. ...
There are two kinds of IBD: Crohns disease and ulcerative colitis. ... Inflammatory bowel disease is an ongoing illness caused by an inflammation of the intestines. ... What Is Inflammatory Bowel Disease?. Inflammatory bowel disease (IBD) causes parts of the intestine (bowel) to get red and ... How Is Inflammatory Bowel Disease Diagnosed?. If you have any of the symptoms of IBD, its important to see your doctor. The ...
Inflammatory Bowel Disease Information Including Symptoms, Diagnosis, Treatment, Causes, Videos, Forums, and local community ... What causes inflammatory bowel disease?. The exact cause of inflammatory bowel disease (IBD) is not known. It is known to run ... How is inflammatory bowel disease treated?. Currently, there is no cure for inflammatory bowel disease (IBD). The goal of ... What is inflammatory bowel disease?. Inflammatory bowel disease (IBD) occurs when inflammation in the small intestine and colon ...
inflammatory bowel disease Clinical Research Trial Listings on CenterWatch ... Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome) Aim More insight in pathogenesis of ... Exercise and Irritable Bowel Syndrome (IBS) (AF_IBS) Specific Aim 1: As shown in the literature, exercise can be a useful tool ... Background Chronic granulomatous disease (CGD) affects the immune system. People with CGD are more likely to get infections. ...
CrohnsAndColitis.com provides information and resources about Crohns and Colitis disease. CrohnsAndColitis.com assists ... Crohns Disease and ulcerative colitis and to improving the quality of life of children and adults affected by these diseases. ...
Many complications associated with IBD can occur with either ulcerative colitis or Crohn disease, but others are specific for ... The complications of inflammatory bowel disease (IBD) are generally classified according to the areas involved: the intestinal ... encoded search term (Complications of Inflammatory Bowel Disease) and Complications of Inflammatory Bowel Disease What to Read ... Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease ...
Inflammatory bowel disease; IBD Stress: Inflammatory Bowel Disease Stress Index; IBDQ: Inflammatory Bowel Disease Questionnaire ... Inflammatory bowel disease; IBDQ: Inflammatory Bowel Disease Questionnaire; MIBDI: Manitoba Inflammatory Bowel Disease Index; ... Inflammatory bowel disease; IBDQ: Inflammatory Bowel Disease Questionnaire; PSKB: Psychic and socio-communicative status ( ... 2001/viewarticle/defining-difficult-treat-inflammatory-bowel-disease-2023a1000i7v. Defining Difficult-to-Treat Inflammatory ...
List of doctors for the Inflammatory Bowel Disease Center at Baylor College of Medicine.... ... Inflammatory Bowel Disease Center * About Inflammatory Bowel Disease (IBD) * Diagnostic Testing for Inflammatory Bowel Disease ... Inflammatory Bowel Disease and Nutrition * Inflammatory Bowel Disease and Pregnancy * Medications for Inflammatory Bowel ...
... occurs when parts of the digestive tract become damaged by prolonged inflammation. ... Disease Inflammatory bowel disease Inflammatory bowel disease occurs when parts of the digestive tract become damaged by ... What is inflammatory bowel disease? Inflammatory bowel disease is a condition in which the lining of the digestive tract ... Symptoms of inflammatory bowel disease The most common symptoms of inflammatory bowel disease are:. *Diarrhoea, often including ...
Inflammatory Bowel Disease. What is inflammatory bowel disease? Inflammatory bowel disease (IBD) is characterized by chronic ... Disorder: Inflammatory Bowel Disease. STASIAS PERSONAL STORY. I have had digistive problems from about age 55 (I am 63 now). ... More recently it seems to be more IBS-D with urgency and even a couple of really upsetting episodes of bowel incontinence. I ... Functional GI and motility disorders which affect the lower GI tract from the small intestine/bowel, to the large intestine/ ...
Chronic diarrhea and belly pain could be caused by inflammatory bowel disease. Learn about IBD causes, diagnosis and treatment. ... Expert explains how inflammatory bowel disease, irritable bowel syndrome differ Oct. 14, 2022, 02:00 p.m. CDT ... and diagnosis of inflammatory bowel diseases. In: Sleisenger and Fordtrans Gastrointestinal and Liver Disease: Pathophysiology ... Symptoms of inflammatory bowel disease may first prompt a visit to your primary health care provider. However, you may then be ...
News-Medical is your trusted source of Inflammatory Bowel Disease news, articles and research for doctors, patients, and ... Inflammatory Bowel Disease News and Research. Latest Inflammatory Bowel Disease News and Research. ... Quality of care for inflammatory bowel disease patients can be improved Inflammatory bowel disease (IBD) is a chronic recurrent ... What is believed to be the largest study of its kind for the genetic roots of inflammatory bowel diseases has suggested new ...
Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. ... Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. ... CD4+ T Cells in Inflammatory Bowel Disease (IBD). Inflammatory bowel disease is a complex set of diseases that includes Crohns ... Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis ( ...
Researchers at UC San Diego School of Medicine report that the lasting nature of inflammatory bowel disease may be due to a ... Gastroenterology Inflammatory Bowel Disease IBD Ulcerative Colitis Cell Biology Immunology Autoimmune Diseases Immune Response ... Inflammatory Bowel Disease Linked to an Immune Cell Run Amok. New findings may provide new therapeutic target and help explain ... Inflammatory bowel disease (IBD) is a group of intestinal disorders affecting an estimated six to eight million people ...
Pair a medical ID for inflammatory bowel disease with MedicAlert membership and be assured of 24/7 protection in an emergency. ... Inflammatory bowel disease is an umbrella term that is used to describe two primary types of IBD: Crohns disease and ... While no single test can diagnose inflammatory bowel disease, the process typically begins with a questionnaire about your ... Thats why medical IDs for inflammatory bowel disease play an important role in comprehensive plans for managing IBD.. ...
... Inflamm Bowel Dis. 2005 Aug;11(8):733 ... Background: Endoscopic and radiologic studies are frequently required in inflammatory bowel disease (IBD) to determine disease ... Results: PET correctly identified active inflammatory disease in 80% of children with IBD (81.5% with Crohns disease; 76.4% ... Thirty-eight patients had Crohns disease (17 ileal, 12 ileocolic, 5 pancolonic, 3 left-sided disease, 1 right-sided disease), ...
Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory ... and Prevention of Infectious Diseases in Pediatric Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor - ... Pediatric Inflammatory Bowel Disease - Evaluation and Management - Full Reference Set. The PowerPoint version of these slides ... Skeletal Health of Children and Adolescents With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and ...
In this Review, Vande Casteele and colleagues summarize the mechanistic role of IL-12 and IL-23 in inflammatory bowel disease, ... IL-12 and IL-23 have been implicated in inflammatory bowel disease. ... have a key role in intestinal homeostasis and inflammation and are implicated in the pathogenesis of inflammatory bowel disease ... Upon their secretion by antigen-presenting cells, they exert both pro-inflammatory and anti-inflammatory receptor-mediated ...
... diseases, ulcerative colitis (UC) and Crohn's disease (CD), was created at the University of Puerto Rico in 1995. Subjects ... All entries from 1995 to 2009 were analyzed for demographics, family history, disease extent, extraintestinal manifestations, ... "Inflammatory bowel disease and African Americans: a systematic review," Inflammatory Bowel Diseases, vol. 14, no. 7, pp. 960- ... "Effect of race and ethnicity on perceptions of inflammatory bowel disease," Inflammatory Bowel Diseases, vol. 12, no. 6, pp. ...
Drug Administration has approved the use of fecal calprotectin testing to aid in the diagnosis of inflammatory bowel disease ( ... IBD) in adults and children presenting with gastrointestinal symptoms, and differentiating IBD from irritable bowel syndrome.1 ... Diagnosis of inflammatory bowel disease. Patients with symptoms suggestive of inflammatory bowel disease vs. irritable bowel ... Test strategies to predict inflammatory bowel disease among children with nonbloody diarrhea. Pediatrics. 2020;146(2):e20192235 ...
See a full list here of Hoags Digestive Health Institute locations.
... is a debilitating group of chronic diseases including Crohns Disease (CD) and ulcerative colitis (UC), which causes ... and how they are connected across different disease conditions at the global scale. In this study, using faecal samples from ... Inflammatory bowel disease (IBD), is a debilitating group of chronic diseases including Crohns Disease (CD) and ulcerative ... Inflammatory bowel disease (IBD), a group of chronic intestinal disorders including Crohns disease (CD) and ulcerative colitis ...
We determined members of the ECS and related components of the endocannabinoidome in patients with inflammatory bowel disease ... Anandamide (AEA) and oleoylethanolamide (OEA) were increased in plasma of ulcerative colitis (UC) and Crohns disease (CD) ... Inflammatory bowel disease (IBD) and colorectal cancer (CRC) are severe diseases of the gastrointestinal tract (GI). The two ... in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohns disease. ...
Some genes have opposing effects, raising the risk of one disease while protecting against the other. In other cases, a gene ... Pediatric researchers analyzing DNA variations in type 1 diabetes and inflammatory bowel disease have found a complex interplay ... variant may act in the same direction, raising the risk for both diseases. ... Inflammatory bowel disease consists of Crohns disease (CD), which may affect the entire digestive tract, but especially the ...
Pathology provides studies of the cells lining the intestines and the colon to find out what is causing inflammation.
"Inflammatory Bowel Diseases"[Mesh] OR "inflammatory bowel disease"[tw] OR "inflammatory bowel diseases"[tw] OR "IBD"[tw] OR " ... "inflammatory bowel disease"/exp OR "inflammatory bowel diseases"/exp OR "ibd" OR "crohn" OR "colitis"/exp) AND [embase]/lim. ... specificity of faecal calprotectin test in distinguishing inflammatory bowel disease from non-inflammatory bowel disease. Plots ... graph of faecal calprotectin test in distinguishing inflammatory bowel disease from non-inflammatory bowel disease, with 95% ...
  • Inflammatory bowel disease (IBD) is a term for two conditions (Crohn's disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal (GI) tract. (cdc.gov)
  • Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, Crohn's disease and ulcerative colitis (UC) being the principal types. (wikipedia.org)
  • Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum. (wikipedia.org)
  • A 2022 study found that diets with increased intake of fruits and vegetables, reduction of processed meats and refined carbohydrates, and preference of water for hydration were associated with lower risk of active symptoms with IBD, although increased intake of fruits and vegetables alone did not reduce risk of symptoms with Crohn's disease. (wikipedia.org)
  • Gluten sensitivity was reported in 23.6% and 27.3% of Crohn's disease and ulcerative colitis patients, respectively. (wikipedia.org)
  • There are two kinds of IBD: Crohn's disease and ulcerative colitis. (kidshealth.org)
  • Crohn's disease can happen in any part of the gastrointestinal tract from mouth to anus (where poop comes out). (kidshealth.org)
  • Crohn's disease damages the entire bowel wall. (kidshealth.org)
  • IBD includes two distinct conditions, ulcerative colitis and Crohn's disease. (healthgrades.com)
  • Although both conditions involve inflammation and produce somewhat similar symptoms, in Crohn's disease, the inflammation can extend to other organs in the digestive tract, including the stomach and esophagus, while ulcerative colitis specifically affects the colon (large intestine). (healthgrades.com)
  • Crohn's disease affects the full thickness of intestine, resulting in significant scarring and fistula formation. (healthgrades.com)
  • Crohn's disease is diagnosed most commonly in people from most commonly 20 to 30 years of age. (healthgrades.com)
  • Symptoms of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, primarily affect the digestive tract and include appetite loss, diarrhea, weight loss, rectal bleeding , nausea , and abdominal cramping. (healthgrades.com)
  • The Crohn's & Colitis Foundation of America (CCFA) a non-profit, volunteer-driven organization dedicated to finding the cures for Crohn's Disease and ulcerative colitis and to improving the quality of life of children and adults affected by these diseases. (virginia.gov)
  • [ 1-3 ] The inflammatory bowel diseases (IBDs) - Crohn's disease (CD) and ulcerative colitis (UC) - were classified as psychosomatic disorders, with early studies reporting a close association between IBD and psychiatric diagnoses. (medscape.com)
  • The two most common types, Crohn's disease and ulcerative colitis, are serious chronic illnesses with no known cause. (edu.au)
  • Crohn's disease, which can occur anywhere in the digestive tract from the mouth to the anus, and which inflames the entire thickness of the intestinal wall. (edu.au)
  • Some people are diagnosed with 'indeterminate colitis', when their inflammatory bowel disease cannot be distinguished between ulcerative colitis and Crohn's disease. (edu.au)
  • The inflammation in Crohn's disease and colitis is not limited to the intestine. (edu.au)
  • What causes Crohn's disease? (edu.au)
  • Crohn's disease and ulcerative colitis are inflammatory conditions. (edu.au)
  • Crohn's disease can occur following an infectious gastroenteritis. (edu.au)
  • Some research suggests Crohn's disease may be triggered by the bacterium Mycobacterium avium subspecies paratuberculosis (related to the bacterium that causes tuberculosis ). (edu.au)
  • Environmental and lifestyle influences such as tobacco use and diet as well as alteration in the bacterial composition of the bowel, called the microbiome, also have an effect on the development of Crohn's disease. (edu.au)
  • Crohn's disease and ulcerative colitis are the most common disorders. (iffgd.org)
  • If one has a narrowing in the small bowel related to Crohn's disease, something called a stricture, diet becomes very important because if certain patients eat foods that have too much roughage or fiber, then those types of foods can cause an impaction or block the narrowing in the small bowel, leading to signs and symptoms of something we call an obstruction: Belly pain, vomiting, loud noises in the bowel. (mayoclinic.org)
  • Generally the risk is slightly higher for Crohn's disease than ulcerative colitis. (mayoclinic.org)
  • A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. (news-medical.net)
  • Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. (news-medical.net)
  • An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease. (news-medical.net)
  • What is believed to be the largest study of its kind for the genetic roots of inflammatory bowel diseases has suggested new links to Crohn's Disease as well as further evidence that some people of Jewish descent are more likely to develop it. (news-medical.net)
  • Inflammatory bowel disease is a complex set of diseases that includes Crohn's disease (CD) and ulcerative colitis (UC), each with multiple bacterial, immune, and non-immune cell types contributing to inflammation. (frontiersin.org)
  • Crohn's disease causes pain, swelling, and inflammation in the gastrointestinal tract, specifically, the upper part of the large intestine and the small intestine. (medicalert.org)
  • Scientific evidence suggest that 5% to 20% of people living with IBD have a parent, sibling or child with Crohn's disease or UC. (medicalert.org)
  • The risk of IBD being hereditary is greater with Crohn's disease and when both parents had/have the disease. (medicalert.org)
  • Symptoms of Crohn's disease and ulcerative colitis are very similar. (medicalert.org)
  • Thirty-eight patients had Crohn's disease (17 ileal, 12 ileocolic, 5 pancolonic, 3 left-sided disease, 1 right-sided disease), and 17 had ulcerative colitis (15 pan-colitis, 2 left-sided colitis). (nih.gov)
  • This Review provides a summary of the biology of the IL-12 family cytokines IL-12 and IL-23, discusses the role of these cytokines in intestinal homeostasis and inflammation, and highlights IL-12- and IL-23-directed drug development for the treatment of Crohn's disease and ulcerative colitis. (nature.com)
  • Multiple IL-12- and/or IL-23-neutralizing antibodies have been tested in immune-mediated diseases, including Crohn's disease and ulcerative colitis. (nature.com)
  • A registry of patients with inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease (CD), was created at the University of Puerto Rico in 1995. (hindawi.com)
  • Inflammatory bowel disease (IBD), is a debilitating group of chronic diseases including Crohn's Disease (CD) and ulcerative colitis (UC), which causes inflammation of the gut and affects millions of people worldwide. (springer.com)
  • Anandamide (AEA) and oleoylethanolamide (OEA) were increased in plasma of ulcerative colitis (UC) and Crohn's disease (CD) patients while 2-arachidonoylglycerol (2-AG) was elevated in patients with CD, but not UC. (nature.com)
  • Inflammatory bowel disease consists of Crohn's disease (CD), which may affect the entire digestive tract, but especially the small intestine, and ulcerative colitis (UC), mainly affecting the large intestine. (scienceblog.com)
  • They also found four variants impacting the genes PTPN22, IL27, IL18RAP and IL10 that raised the risk of T1D while lowering the risk of Crohn's disease. (scienceblog.com)
  • He noted that a pathogen could interact with a gene that raises the risk for type 1 diabetes at the same time it confers protection from Crohn's disease. (scienceblog.com)
  • 1 2 The disorder includes two major forms of chronic intestinal inflammation: Crohn's disease and ulcerative colitis. (bmj.com)
  • Crohn's disease, ulcerative colitis, and celiac disease are chronic inflammatory bowel diseases with a relatively high prevalence in Western countries. (rug.nl)
  • This thesis describes research into the genetic factors involved in Crohn's disease, ulcerative colitis and celiac disease. (rug.nl)
  • A screen for variants in genes in the innate immune system was used to identify new risk genes for Crohn's disease and ulcerative colitis. (rug.nl)
  • Mount Sinai has a long history of combining leading-edge research and world-class surgical experience in treating inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. (mountsinai.org)
  • Dr. Burrill B. Crohn first described Crohn's disease here at Mount Sinai in 1932, and our colon and rectal surgeons have remained leaders in the treatment of these disorders. (mountsinai.org)
  • In addition, our colon and rectal surgeons are involved in leading-edge research with participation in large, multi-center clinical trials in order to develop new and better therapies for Crohn's disease and ulcerative colitis. (mountsinai.org)
  • Crohn's disease is an autoimmune disorder that causes chronic inflammation in the lining of the gastrointestinal tract, sometimes extending deep into the layers of bowel tissue. (mountsinai.org)
  • Crohn's Disease can be both painful and debilitating, and sometimes may lead to life-threatening complications. (mountsinai.org)
  • There is no known cure for Crohn's disease, but there are therapies, including surgery, that can greatly reduce the symptoms and in some cases, lead to long-term remission. (mountsinai.org)
  • When symptoms of Crohn's disease are not responding to medication, your physician may recommend surgery, especially if there are complications, such as bleeding, fistulas, infections, or narrowing of the bowel. (mountsinai.org)
  • The colon and rectal surgeons at Mount Sinai have a long history in the surgical treatment of Crohn's disease, which was discovered at Mount Sinai in 1932. (mountsinai.org)
  • While surgery will not cure Crohn's disease, it often can improve quality of life for patients. (mountsinai.org)
  • Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, involves chronic inflammation of the gastrointestinal tract. (cdc.gov)
  • Data on diagnosed IBD (hereafter referred to as IBD) were collected with the Sample Adult Core questionnaire using the following question: "Have you ever been told by a doctor or other health professional that you had Crohn's disease or ulcerative colitis? (cdc.gov)
  • Inflammatory bowel disease (IBD) refers to two conditions, ulcerative colitis and Crohn's disease, which are caused by a malfunctioning immune system. (harvard.edu)
  • In Crohn's disease, this inflammation can occur anywhere in the digestive tract, while colitis affects only the colon and the rectum. (harvard.edu)
  • Inflammatory bowel disease is an umbrella term that includes many conditions, the two most common being Crohn's disease and ulcerative colitis (UC). (holtorfmed.com)
  • The main difference between Crohn's disease and UC lies in which the parts of the digestive tract each condition affects. (holtorfmed.com)
  • Crohn's disease can cause inflammation to any part of the digestive tract, most commonly the small intestine, while UC only involves the inflammation of the large intestine. (holtorfmed.com)
  • Inflammatory bowel disease (IBD) comprises ulcerative colitis and Crohn's disease. (contemporaryobgyn.net)
  • 3 Interestingly, smoking increases risk of Crohn's disease while smoking cessation increases risk of ulcerative colitis. (contemporaryobgyn.net)
  • Crohn's disease can occur anywhere in the gastrointestinal tract from mouth to anus, although the terminal ileum is the most common site. (contemporaryobgyn.net)
  • While we are classically taught granulomas on biopsy are diagnostic of Crohn's disease, less than one-third of biopsies show these findings (Table 1). (contemporaryobgyn.net)
  • Unlike in ulcerative colitis, oral 5-aminosalicylates are not found to be effective in Crohn's disease, and biologics and/or immunomodulators are preferentially used. (contemporaryobgyn.net)
  • Inflammatory bowel disease (IBD) is represented by Crohn's disease (CD) and ulcerative colitis (UC). (karger.com)
  • ulcerative colitis (UC) (n = 20), Crohn's disease (CD) (n = 10) were prospectively assessed in addition to 20 non-IBD participants representing the control group. (scirp.org)
  • 1976) Development of a Crohn's disease activity index. (scirp.org)
  • National Cooperative Crohn's Disease Study. (scirp.org)
  • 2002) A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. (scirp.org)
  • 2006) Bowel ultrasound in Crohn's disease. (scirp.org)
  • BACKGROUND: The occurrence of Crohn's disease (CD) and ulcerative colitis (UC) is shaped by environmental influences. (cdc.gov)
  • The U.S. Food and Drug Administration has approved the use of fecal calprotectin testing to aid in the diagnosis of inflammatory bowel disease (IBD) in adults and children presenting with gastrointestinal symptoms, and differentiating IBD from irritable bowel syndrome. (aafp.org)
  • Are inflammatory bowel disease and irritable bowel syndrome the same? (harvard.edu)
  • I was recently diagnosed with irritable bowel syndrome. (harvard.edu)
  • While people with irritable bowel syndrome (IBS) may experience some of the same symptoms as people with IBD, there is no obvious inflammation within the digestive tract. (harvard.edu)
  • Gut conditions are becoming a growing concern in the United States with Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) being two of the most common. (holtorfmed.com)
  • What is Irritable Bowel Syndrome? (holtorfmed.com)
  • Irritable Bowel Syndrome is a common disorder that affects the lower gastrointestinal tract. (holtorfmed.com)
  • IBS is irritable bowel syndrome. (memorialcare.org)
  • Irritable bowel syndrome (IBS) is the same as inflammatory bowel disease (IBD). (medlineplus.gov)
  • In the long-term, people with inflammatory bowel disease are at elevated risk of bowel cancer . (edu.au)
  • And so, people with inflammatory bowel disease usually have some genetic predisposition for autoimmunity, like there's some other autoimmune diseases in the family. (memorialcare.org)
  • The mucosal microbiota in the large intestine of IBD patients with active inflammation was found to be associated with pro-inflammatory changes to the host epigenome. (wikipedia.org)
  • For example, a retrospective, case control study of 108 patients with Crohn disease found that those with a fixed small bowel stricture on cross-sectional imaging were more likely to have complications. (medscape.com)
  • Fistulae and abscesses are much more common in Crohn disease, but they are observed in about 20% of patients with ulcerative colitis. (medscape.com)
  • Perianal complications occur in 90% of patients with Crohn disease. (medscape.com)
  • It's been well studied that actually inflammatory bowel disease does not significantly change the overall lifespan of the patients. (mayoclinic.org)
  • There's multiple lines of research that when patients with inflammatory bowel disease are controlled against patients their same age, with their same medical problems, without inflammatory bowel disease, achieve roughly the same lifespan. (mayoclinic.org)
  • A new survey cautions physicians that drugs commonly prescribed for patients suffering from immunological disorders such as rheumatoid arthritis and inflammatory bowel disease may carry risks of serious infections other than the known risk of tuberculosis. (news-medical.net)
  • A new Mayo Clinic study finds that patients who are 50 or older and take multiple immunosuppressive medications for inflammatory bowel disease have a higher risk for developing infections. (news-medical.net)
  • In these studies, CD4 + T cell-depleting and blocking antibodies caused remission from disease in a number of CD and UC patients examined, suggesting a prominent role of CD4 + T cells in propagating disease ( 1 , 2 ). (frontiersin.org)
  • Finally, a number of biologics that target CD4 + T cell differentiation into inflammatory subsets or their byproducts (i.e., cytokines) have shown efficacy in treating patients with IBD ( 5 - 7 ). (frontiersin.org)
  • We found that this inflammatory T RM cell subtype seemed to be enriched in the intestinal tissues of patients with ulcerative colitis, a form of IBD that affects the colon," said Chang. (newswise.com)
  • Gluorine-18-fluoro-deoxyglucose accumulated at sites that corresponded with active disease at colonoscopy in 83.8% of patients and with small bowel follow-through with pneumocolon 75.0% of the time. (nih.gov)
  • We determined members of the ECS and related components of the 'endocannabinoidome' in patients with inflammatory bowel disease (IBD) and CRC, and compared them to control subjects. (nature.com)
  • The IBD and T1D samples were all from patients with early-onset disease, i.e., occurring by age 19. (scienceblog.com)
  • Inclusion criteria Studies that had collected data prospectively in patients with suspected inflammatory bowel disease and allowed for construction of a two by two table. (bmj.com)
  • Conclusion Testing for faecal calprotectin is a useful screening tool for identifying patients who are most likely to need endoscopy for suspected inflammatory bowel disease. (bmj.com)
  • Endoscopic evaluation with histopathological sampling are generally considered indispensable in the investigation of patients with suspected inflammatory bowel disease. (bmj.com)
  • 3 4 Many patients consider endoscopy and the required bowel preparation to be uncomfortable. (bmj.com)
  • In the last few decades, a better knowledge of the inflammatory pathways involved in the pathogenesis of Inflammatory Bowel Disease (IBD) has promoted biological therapy as an important tool to treat IBD patients. (mdpi.com)
  • Patients are usually bound to strict diets and/or anti-inflammatory drugs. (rug.nl)
  • We tend to focus a lot on the severe, very sick patients, but there are going to be patients who have mild disease, who are at low risk for complications. (hcplive.com)
  • For patients with ulcerative colitis mild disease, there may still be a role for both oral and rectal 5-ASA [aminosalicylate] therapy to both induce and maintain remission. (hcplive.com)
  • In your patients with Crohn disease, especially those with mild isolated ileal disease, you could think about budesonide, of course, as well. (hcplive.com)
  • Still assessing these patients, especially up front, to ensure that you induced remission and you are maintaining appropriately is critical because a lot of these patients, especially those with isolated rectal disease, often get put into a low-risk box, and they're continually on rectal steroids or courses of steroids because people don't want to advance those patients to biologics because their disease is somewhat more limited. (hcplive.com)
  • Those patients can have severe disease too, and it can have bad outcomes. (hcplive.com)
  • Liverani E, Scaioli E, Digby RJ, Bellanova M, Belluzzi A. How to predict clinical relapse in inflammatory bowel disease patients. (wjgnet.com)
  • 1 Small bowel CD patients excluded. (wjgnet.com)
  • This activity is intended for gastroenterologists, primary care physicians (PCPs), nurses, and other healthcare providers (HCPs) involved in the management of patients with inflammatory bowel disease (IBD). (medscape.org)
  • Inflammatory bowel disease (IBD) affects patients during their peak reproductive years. (karger.com)
  • You must be an appropriately qualified healthcare professional actively connected to clinical practice and able to demonstrate ongoing experience of caring for patients with inflammatory bowl disease, e.g. (salford.ac.uk)
  • For the last century, inflammatory bowel disease (IBD) has been a challenge for patients and the medical community in the western world. (earthscape.org)
  • Bowel wall thickness, peri-enteric changes, and hemodynamic changes in the portal vein and mesenteric arteries were recorded at initial enrollment and after complete remission in 10 IBD patients. (scirp.org)
  • Clinical Experience of the Use of CT-P13, a Biosimilar to Infliximab in Patients with Inflammatory Bowel Disease: A Case Series. (smw.ch)
  • The aim of the current study was to assess the outcomes associated with Lacanian psychoanalytical therapy involving patients with inflammatory bowel disease. (bvsalud.org)
  • It is the most common intestinal problem that brings patients to a bowel specialist (gastroenterologist). (medlineplus.gov)
  • Characteristics of Facilities With Early and Rapid Ustekinumab Adoption for Patients With Inflammatory Bowel Disease. (bvsalud.org)
  • RESULT: A total of 3110 inflammatory bowel disease (IBD) patients were included in the present analysis. (cdc.gov)
  • Une étude a été menée dans des unités de soins intensifs en chirurgie pour adultes de l'hôpital universitaire de Zagazig, (Égypte) auprès de 25 patients atteints de septicémie, de 27 patients atteints d'une septicémie sévère et de 28 témoins. (who.int)
  • In patients with widespread disease, careful consideration must be given to potential adverse effects. (medscape.com)
  • IBD is a complex disease which arises as a result of the interaction of environmental and genetic factors leading to immunological responses and inflammation in the intestine. (wikipedia.org)
  • Inflammatory bowel disease (IBD) causes parts of the intestine (bowel) to get red and swollen (inflammation). (kidshealth.org)
  • IBD is treated with anti-inflammatory medicines, including steroids, to reduce inflammation. (kidshealth.org)
  • Inflammatory bowel disease (IBD) occurs when inflammation in the small intestine and colon produces redness, bleeding and pus , which, in turn, cause such symptoms as diarrhea. (healthgrades.com)
  • Inflammatory bowel disease occurs when parts of the digestive tract become damaged by prolonged inflammation. (edu.au)
  • Our research into the causes of inflammation aims to reveal new treatments for inflammatory bowel disease. (edu.au)
  • The cause of intestinal inflammation in inflammatory bowel disease. (edu.au)
  • Ulcerative colitis, in which inflammation is limited to the surface layers of the large bowel (colon). (edu.au)
  • However in inflammatory bowel disease, unnecessary inflammation is triggered. (edu.au)
  • Chang said the findings may help to explain why IBD is chronic and life-long, and point to the possibility of a remedy in the future: Targeting this inflammatory T RM cell subtype for elimination, thus ending the cycle of inflammation and tissue damage. (newswise.com)
  • More common in Asia and the Middle East, Behçet's is a type of autoimmune disease that causes inflammation in the blood vessels. (medicalert.org)
  • The aim of this study was to assess the value of PET in identifying active intestinal inflammation compared with conventional endoscopic and radiologic studies, including small bowel follow-through and colonoscopy. (nih.gov)
  • Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in the pathogenesis of inflammatory bowel disease. (nature.com)
  • IL-12 and IL-23, which are members of the IL-12 family of cytokines, have a key role in intestinal homeostasis and inflammation, including in inflammatory bowel disease. (nature.com)
  • Both CD and UC diseases are differentiated by their location and levels of inflammation in the gastrointestinal (GI) tract. (springer.com)
  • Objective To evaluate whether including a test for faecal calprotectin, a sensitive marker of intestinal inflammation, in the investigation of suspected inflammatory bowel disease reduces the number of unnecessary endoscopic procedures. (bmj.com)
  • Finally, intestinal inflammation led to mitochondrial dysfunction in the apical domain of the surface epithelium that may reduce the consumption of fatty acids, contributing to higher concentrations of fecal acylcarnitines in murine Citrobacter rodentium-induced colitis and human inflammatory bowel disease. (jci.org)
  • Inflammatory Bowel Disease is the term for a group of intestinal disorders that cause prolonged inflammation of the digestive tract, one of the largest organs in the body. (holtorfmed.com)
  • In contrast, IBD is an autoimmune condition that is characterized by the inflammation or even destruction of the bowel wall, which can lead to sores and narrowing of the intestines. (holtorfmed.com)
  • Inflammatory bowel disease or IBD, is a chronic disease characterized by chronic inflammation of the gastrointestinal tract. (memorialcare.org)
  • And the other more I guess the most insidious kind of complication of inflammatory bowel disease, is that over the years, maybe even decades of relapsing and remitting inflammation, you start to get architectural changes, when the skin repairs itself or when the intestines repairs itself. (memorialcare.org)
  • The findings are relevant for our better understanding of the pathogenesis of inflammatory bowel diseases and to further research in therapeutic treatments. (rug.nl)
  • Many complications associated with IBD can occur with either ulcerative colitis or Crohn disease, but others are specific for each condition. (medscape.com)
  • both findings are not uncommon in persons with Crohn disease (see the images below). (medscape.com)
  • Crohn disease involving the terminal ileum. (medscape.com)
  • How do you approach mild UC [ulcerative colitis] and mild Crohn disease? (hcplive.com)
  • Then, Crohn disease is a little bit trickier. (hcplive.com)
  • Refer a patient to Tufts Medical Center's Department of Gastroenterology for Inflammatory Bowel Disease, Crohn Disease, and Ulcerative Colitis care. (tuftsmedicalcenter.org)
  • Crohn disease n=2) in which a therapeutic effect from psychoanalysis was observed. (bvsalud.org)
  • IBD includes Crohn disease and ulcerative colitis, conditions that damage the lining of the digestive tract. (medlineplus.gov)
  • The study of Crohn's (CD) and ulcerative colitis (UC) has been focused on Caucasians, as the incidence and diagnosis of inflammatory bowel disease (IBD) have been more evident in this population. (hindawi.com)
  • A veterinarian will normally examine the intestines for a definitive diagnosis of inflammatory bowel disease if all other illnesses that present the same symptoms as IBD are ruled out with testing. (aspcapetinsurance.com)
  • Di Sabatino, A., Armellini, E. and Corazza, G.R. (2004) Doppler sonography in the diagnosis of inflammatory bowel disease. (scirp.org)
  • Both genetic and environmental factors are important contributors to inflammatory bowel disease. (edu.au)
  • Specific genetic changes have been found that increase the risk of developing inflammatory bowel disease. (edu.au)
  • So most people have the right genetic makeup for this disease but don't actually develop the disease. (mayoclinic.org)
  • The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions, two scientists told the annual conference of the European Society of Human Genetics today (Monday 2 June). (news-medical.net)
  • This finding shows the genetic architecture of these diseases is more complex than previously thought," said study leader Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at The Children's Hospital of Philadelphia. (scienceblog.com)
  • Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects," Human Molecular Genetics , advance access published Feb. 22, 2010. (scienceblog.com)
  • It was also found that there is overlap in genetic risk between these diseases and celiac disease. (rug.nl)
  • The exact cause of inflammatory bowel disease in cats is unknown, but some suspected causes are genetic factors, hypersensitivity to bacteria, and immunology factors. (aspcapetinsurance.com)
  • A diet high in protein, particularly animal protein, and/or high in sugar may be associated with increased risk of inflammatory bowel disease and relapses. (wikipedia.org)
  • Other inflammatory diseases of the gastrointestinal tract that could cause false-positives include gastric or colorectal cancer, lymphoma, autoimmune enteropathy, diverticular disease, and microscopic or infectious colitis. (aafp.org)
  • Inflammatory bowel disease (IBD) and colorectal cancer (CRC) are severe diseases of the gastrointestinal tract (GI). (nature.com)
  • Dysfunction of the innate immune system as a result of abnormal signaling through immune receptors called toll-like receptors (TLRs)-which activates an immune response to molecules that are broadly shared by multiple pathogens-contributes to acute and chronic inflammatory processes in IBD colitis and associated cancer. (wikipedia.org)
  • Both forms of IBD affect young adults, with disease onset usually occurring between ages 15 and 30 years, and less commonly between 50 and 70 years of age for ulcerative colitis. (healthgrades.com)
  • CrohnsAndColitis.com provides information and resources about Crohn's and Colitis disease. (virginia.gov)
  • For more information about inflammatory bowel disease, please visit Crohn's and Colitis Australia . (edu.au)
  • Rarer types of IBD include microscopic colitis (MC), diversion colitis, and Behçet's disease. (medicalert.org)
  • The way I look at ulcerative colitis is this: it's almost 2 flavors, and I don't want to simplify it, because it's multiple diseases. (hcplive.com)
  • Biologics are effective and have a good safety profile in the treatment of inflammatory bowel disease. (smw.ch)
  • Inflammatory bowel disease is a condition in which the lining of the digestive tract becomes inflamed and damaged. (edu.au)
  • In these diseases, the immune system misfires, causing the lining of the digestive tract to become chronically inflamed and irritated. (harvard.edu)
  • Unfortunately, oftentimes a digestive problem is not detected until disease is diagnosed or the onset of severe symptoms appear. (holtorfmed.com)
  • Our digestive health constitutes 75% of our immune system for fighting off disease. (holtorfmed.com)
  • Poor digestive health not only diminishes the ability to fight disease, but it can also affect the function of your metabolism, which is needed for maintaining a healthy weight. (holtorfmed.com)
  • Digestive Diseases and Sciences, 27, 269-277. (scirp.org)
  • Digestive Diseases and Sciences, 22, 6366. (scirp.org)
  • In spite of Crohn's and UC being very different diseases, both may present with any of the following symptoms: abdominal pain, diarrhea, rectal bleeding, severe internal cramps/muscle spasms in the region of the pelvis and weight loss. (wikipedia.org)
  • Title : Health care utilization among U.S. adults with inflammatory bowel disease, 2015-2016 Personal Author(s) : Terlizzi, Emily P.;Dahlhamer, James M.;Xu, Fang;Wheaton, Anne G.;Greenlund, Kurt J. (cdc.gov)
  • Note that barium has just started to enter the cecum in the right lower quadrant (viewer's left), but it has also started to enter the sigmoid colon toward the bottom of the picture, thus indicating the presence of a fistula from the small bowel to the sigmoid colon. (medscape.com)
  • Functional GI and motility disorders which affect the lower GI tract from the small intestine/bowel, to the large intestine/bowel or colon, to the rectum. (iffgd.org)
  • 2007) Inflammatory chronic disease of the colon: How to image. (scirp.org)
  • Inflammatory bowel disease is an autoimmune disease. (memorialcare.org)
  • And so inflammatory bowel disease is an autoimmune disease of the intestines. (memorialcare.org)
  • Inflammatory bowel disease (IBD) is a group of intestinal disorders affecting an estimated six to eight million people worldwide. (newswise.com)
  • Inflammatory bowel disease (IBD) is one of the most common intestinal disorders of cats and a major diagnosis in cats presented with chronic weight loss and gastrointestinal signs. (vin.com)
  • Inflammatory bowel disease was confirmed by endoscopy in 32% (n=215) of the adults and 61% (n=226) of the children and teenagers. (bmj.com)
  • Three of 33 adults who undergo endoscopy will not have inflammatory bowel disease but may have a different condition for which endoscopy is inevitable. (bmj.com)
  • 5 In a relatively large proportion of people with suspected inflammatory bowel disease the results of endoscopy will be negative. (bmj.com)
  • Conversely, doctors would like to be able to identify those with a sufficiently high likelihood of inflammatory bowel disease to justify urgency for endoscopy. (bmj.com)
  • Chang, J. T. Pathophysiology of inflammatory bowel diseases. (nature.com)
  • IBD is considered to represent a heterogenous disorder which is reflected in the variable nature of the inflammatory infiltrate, and the variable clinical manifestations and progress of the disease. (vin.com)
  • Inflammatory bowel disease itself is not an emergency situation, but prolonged diarrhea, a common symptom, can result in serious dehydration or complications. (healthgrades.com)
  • 1994) Sonography of inflammatory bowel disease: Findings and value in differential diagnosis. (scirp.org)
  • The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. (cdc.gov)
  • The underlying cause of IBS is unknown, but symptoms may arise due to uncoordinated intestinal contractions that affect bowel movements and hypersensitive nerves in the gut. (harvard.edu)
  • These signals affect bowel movements. (medlineplus.gov)
  • Anemia is the most prevalent extraintestinal complication of inflammatory bowel disease. (wikipedia.org)
  • Infection, ischaemia, physical damage, or specific immunologic sensitivity should be excluded as far as possible before a diagnosis of non-specific inflammatory bowel disease is made. (nih.gov)
  • This science was actually developed for an infection rather than inflammatory bowel disease. (mayoclinic.org)
  • IBS causes belly pain and abnormal bowel movements but does not harm the intestines. (medlineplus.gov)
  • The main risk factor for cancer would be colorectal or cancer of the large bowel. (mayoclinic.org)
  • A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. (nature.com)
  • The genome-wide association study (GWAS) identified multiple gene variants not previously reported for these diseases, in addition to evaluating genes previously discovered to be associated with one, two or all three diseases. (scienceblog.com)
  • Upon their secretion by antigen-presenting cells, they exert both pro-inflammatory and anti-inflammatory receptor-mediated effects. (nature.com)
  • Because certain chronic conditions are more prevalent among adults with IBD, disease management might involve multidisciplinary clinical care. (cdc.gov)
  • BACKGROUND: Current evidence regarding the association of serum zonulin-related proteins (ZRP) levels with prevalent inflammatory bowel disease (IBD) is contradictory. (lu.se)
  • The survey published is in the June 1 issue of Clinical Infectious Diseases, currently available online. (news-medical.net)
  • 3 The standard of clinical follow-up was added by the authors of the study because of concerns that performing an invasive procedure in a large number of children with a low likelihood of organic gastrointestinal disease would be unethical. (aafp.org)
  • Understanding the health-risk behaviors and prevalence of certain chronic conditions among adults with IBD could inform clinical practice and lead to better disease management. (cdc.gov)
  • Critically analyse the assessment tools used in clinical practice for inflammatory bowel disease to enable a critical evaluation and reflection. (salford.ac.uk)
  • Associated complaints or diseases include arthritis, pyoderma gangrenosum, primary sclerosing cholangitis, and non-thyroidal illness syndrome (NTIS). (wikipedia.org)
  • Because symptoms of IBD are common for many other diseases and food allergies, the diagnostic testing can be extensive. (aspcapetinsurance.com)
  • Vucelic, B. (2009) Inflammatory bowel diseases: Controversies in the use of diagnostic procedures. (scirp.org)
  • MacKalski, B.A. and Bernstein, C.N. (2006) New diagnostic imaging tools for inflammatory bowel disease. (scirp.org)
  • Fistulae and perianal disease may be refractory to vigorous medical treatment, including antibiotic therapy (see the following image). (medscape.com)
  • Standard treatment for IBD includes anti-inflammatory agents, such as aminosalicylic acid as well as immunomodulators, steroids, and biological agents. (nature.com)
  • 3 Certain environmental exposures such as frequent antibiotic use in childhood, low vitamin D levels, frequent nonsteroidal anti-inflammatory drug use, and diets high in processed, sugary, or fried foods may increase risk for IBD. (contemporaryobgyn.net)
  • Management of Stress in Inflammatory Bowel Disease: A Therapeutic Option? (medscape.com)
  • Long-lived memory cells are a goal of vaccines, but this finding suggests that these same cells, coveted in the fight against infectious diseases, may actually be harmful in the context of IBD. (newswise.com)
  • The complications of inflammatory bowel disease (IBD) are generally classified according to the areas involved: the intestinal tract itself (local) or the rest of the organ systems (systemic). (medscape.com)
  • A false-negative fecal calprotectin result in a patient with IBD could lead to a delay in diagnosis, persistence of symptoms, or additional complications of uncontrolled disease. (aafp.org)
  • The discriminative power to safely exclude inflammatory bowel disease was significantly better in studies of adults than in studies of children. (bmj.com)
  • The incidence of inflammatory bowel disease is on the increase in both adults and children. (bmj.com)
  • As teens with inflammatory bowel disease (IBD) become adults, the health care provider who oversees their care will switch from a pediatric gastroenterologist to an adult provider. (kidshealth.org)
  • In 2015, an estimated 3 million U.S. adults had inflammatory bowel disease (IBD). (cdc.gov)
  • Adults with IBD who have mild to moderate disease activity should be encouraged to consult their clinicians about their exercise engagement. (cdc.gov)
  • For those with milder disease, the mainstay for therapy includes oral or rectal administration of 5-aminosalicylates. (contemporaryobgyn.net)
  • As a result of microbial symbiosis and immunity, alterations in the gut microbiome may contribute to inflammatory gut diseases. (wikipedia.org)
  • I think most simply, it depends on where in the bowel the disease is affecting and how severe your case is. (mayoclinic.org)
  • For those with more moderate to severe disease, immunomodulators (5-mercaptopurine or azathioprine) and biologic medications (Table 3) are more effective. (contemporaryobgyn.net)

No images available that match "inflammatory bowel diseases"